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Certain phytochemicals act as potential cancer chemopreventive 
agents in part by inducing phase II  carcinogen-detoxifying enzymes. A 
number of carcinogens are initially metabolized to proximate carcinogens 
by phase  enzymes and the resulting reactive metabolites are then I 
detoxified by phase II enzymes.  NAD(P)H:quinone reductase (QR) is a 
major phase II enzyme that catalyzes the two-electron reduction of various 
quinone compounds and, thereby,  protects  cells from free  radicals 
generated by redox cycling of quinones. Therefore, induction of QR may 
confer protection against the carcinogenicity and toxicity of quinones. The 
objective of the present study was to determine if the flavonoids from hops 
(Humulus lupulus) are inducers of QR both in in vitro and in vivo systems. 
Hops contain unique flavonoids consisting of prenylated chalcones and 
prenylated flavanones.  It is hypothesized that these prenylated flavonoids 
may act as inducers of QR making them potential candidates as cancer 
chemopreventive agents.  To examine this hypothesis, six chalcones 
[xanthohumol (XN); 5'- prenylxanthohumol (PX); 2',4',6',4-tetrahydroxy-3'­
C-prenylchalcone  (TP);  2',4',6',4-tetrahydroxy-3'-geranylchalcone  (TG); 
dehydrocycloxanthohumol (DX) and dehydrocycloxanthohumol hydrate 
(DH)]; and four flavanones [isoxanthohumol (IX); 6-prenylnaringenin (6PN); 
Redacted for Privacy8-prenylnaringenin  (8PN);  and  6,8-diprenylnaringenin  (DPN)]  were 
examined for their ability to induce QR in the mouse hepatoma cell line, 
Hepa 1c1 c7. The cells were exposed to various concentrations (0.1, 1.0, 5, 
10 and 100 1.1M) of these compounds for 2 and 4 days.  Of the 10 hop 
flavonoids tested, XN and DH were the most active  in inducing QR. 
Maximum induction of QR was obtained with XN, at 10 µM for 4 days 
(373% of control values) while DH at 10 pLM for 2 days gave 541cYo of control 
values. TP, TG and IX (the flavanone isomer of XN) caused a maximal 
increase in QR activity at 10 p,M, whereas PX increased QR activity 
maximally at 5µM after 2 days of treatment. 
Similar experiments were performed using rat hepatoma H411E and 
human prostate cancer (LNCaP) cells in order to determine if the hop 
compounds are inducers of rat  and human QR. Unlike in mouse Hepa 
1c1c7 cells, QR induction in rat H411E cells was marginal. For example, XN 
(1 1.1,M) and DH (5 p,M), after 2 days, only induced QR activity, at best, by 
23% and 64%, respectively. At 5 and 10  XN was highly toxic to rat 
H4IIE cells. Lower or no induction of QR in these cells was observed at 
other doses of XN and DH. At 10 12M, IX, TP, TG and DX induced QR by 
23, 49, 43, and 41%, respectively, after 2 days of treatment. In human 
LNCaP cells, DH and XN induced QR 2.4- and 1.9-fold, respectively. 
In some instances, induction of xenobiotic-metabolizing enzymes 
may occur in cell cultures but not in vivo. Therefore, the effects of the hop 
flavonoids on QR activity in mice and rainbow trout were examined. 
Female CD1 mice were gavaged with XN or IX at doses of 5 and 25 mg/kg 
for 4 days and then sacrificed on day 5. Liver, kidney, intestine, and 
stomach cytosol were assayed for QR and glutathione S-transferase (GST) 
activities. QR was increased 26 and 57% in liver of mice treated with 5 
mg/kg of XN and 25 mg/kg of IX, respectively. Animals treated with 25 
mg/kg IX also showed a significant induction in liver and intestine GST. However, treatment of rainbow trout (Oncorhynchus mykiss) with XN (1 or 
10 mg/kg, i.p.) did not produce a significant induction of liver QR or GST. 
Western blot analysis was used to determine possible induction of 
the phase I enzyme, CYP1A1, in the mouse, rat and human tumor cell 
lines. None of the flavonoid treatments induced CYP1A1 in any of these cell 
lines. Instead of increasing CYP1A1 levels, the hop flavonoids actually 
caused a reduction of CYP1A1 in the cell lines. Female CD1 mice treated 
i.p. with XN, IX or p-napthoflavone (BNF, 5 mg/kg dosage as a positive 
control for CYP1A1), at doses of 5 and 25 mg/kg for 4 days and then 
sacrificed on day 5. While CYP1A1 was significantly induced in BNF 
treatment, this P450 enzyme was not induced in animals treated with hop 
flavonoids. 
Taken together, the results of this study suggest that some 
prenylated flavonoids from hops such as XN and DH are effective inducers 
of rodent and human QR.  Induction of QR was greatest in mouse Hepa 
1c1c7 cell line, followed by human LNCaP and rat H4IIE cell lines in that 
order. Induction of QR by XN and IX in mouse liver was not as great as in 
the mouse Hepa 1c1c7 cell line, probably as a result of the low dose of 
flavonoid used and the short duration of treatment employed. The induction 
of QR by XN and DH without accompanying increase in CYP1A1 protein 
indicates that these hop flavonoids are monofunctional inducers of phase II 
enzymes. As monofunctional inducers of QR, the hop flavonoids may be 
promising agents for the prevention of human cancers caused by quinones 
and carcinogens that are detoxified by QR. By decreasing CYP1A1 levels, 
the hop flavonoids may also help prevent the metabolic activation of certain 
procarcinogens such as polycyclic aromatic hydrocarbons. XN was highly 
toxic to rat hepatoma H4IIE cells, suggesting that this flavonoid may further 
act as a therapeutic agent for certain forms of liver tumors. Prenylated Flavonoids From Hops (Humulus lupulus) as Monofunctional 
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INTRODUCTION
 
A number of phytochemicals have been found to have cancer 
chemopreventive activities. These compounds may prevent or inhibit the 
process of carcinogenesis at the stages of  initiation,  promotion, or 
progression (Wattenberg, 1985). At the initiation stage of carcinogenesis, 
chemopreventive agents could  inhibit phase  enzymes that activate I 
chemical carcinogens. Alternatively, these compounds may induce phase II 
enzymes such as quinone reductase (QR), glutathione S-transferase (GST) 
and,  uridine  diphosphate-glucuronosyltransferase (UDPGT) that  are 
involved in the detoxification of carcinogens. 
Induction of QR in cultured mouse hepatoma 1c1c7 cells has been 
used to indicate anticarcinogenic activity of components of the human diet 
such as sulforaphane from broccoli (Zhang et al., 1992; Zhang et al., 1994) 
and resveratrol from grapes (Jang et al., 1997). QR is a widely distributed, 
primarily cytosolic, flavoprotein that catalyzes the reduction of a wide variety 
of quinones and quinoneimines (Prochaska and Santamaria, 1988). QR 
protects cells against the toxicity of xenobiotics by promoting the obligatory 
two-electron reduction of quinones to hydroquinones which are then 
usceptible to glucuronidation and excretion. Measurement of QR activity in 
vitro represents a simple method for screening compounds for their 
potential anticarcinogenic properties. 
Certain synthetic and naturally-occurring chalcone compounds have 
been reported to induce QR in hepatoma 1c1c7 cells (Song et al., 1997; 
Chang et al., 1997). Recently, six chalcones (Figure 1) and four flavanones 2 
Chalcone 
OH 0 
Xanthohumol  Dehydroeycloxanthohumol 
Dehydrocycloxanthohumol hydrate 2',4',6',4-Tetrahydroxy-3'prenylehalcone 
HO 
OH 0 
5'-Prenyhanthohumol 2',4',6',4-Tetrahydroxy-3'-geranylchalcone 
Figure 1: Chemical structure of hop chalcones. 3 
(Figure 2) have been isolated from hops (Humulus lupulus), an ingredient 
used in the brewing industry to give beer its distinct aroma and taste 
(Stevens et al., 1997). The hop flavonoids contain prenyl or geranyl groups 
that may influence the biological activity of these compounds. Certain hop 
compounds inhibit the proliferation of human breast cancer (MCF-7) and 
colon cancer (HT-29) cells in vitro (Miranda et al., 1998). Hop flavonoids 
were also able to inhibit the metabolic activation of aflatoxin B1 mediated by 
rainbow trout liver microsomes and cDNA-expressed human CYP3A4 and 
human CYP1A2 (Henderson et al.,  1998).  The ability of these hop 
flavonoids  to  induce phase  II  detoxifying enzymes has  not been 
established.  It is hypothesized that these compounds may act as potential 
cancer chemopreventive agents in part by inducing QR. 
Induction of phase II detoxifying enzymes such as QR and GST is 
considered a major mechanism of cancer chemoprevention.  Ideally, the 
cancer chemopreventive agent should induce phase II enzymes but not 
phase I enzymes. Induction of phase I  is a potential cancer risk factor due 
to the activation of carcinogens to ultimate carcinogens.  Talalay and 
associates (Prochaska and Talalay, 1988; Talalay, 1992) have classified 
cancer chemopreventive agents as either monofunctional or bifunctional 
inducers of drug-metabolizing enzymes. Monofunctional inducers are those 
that selectively elevate phase II enzymes, whereas bifunctional inducers 
elevate phase  and phase II enzymes. Genistein, an isoflavone from I 
soybeans, is a monofunctional inducer of QR in mouse Hepa 1c1c7 cells 
(Yannai et al., 1998) and does not induce CYP1A in mouse liver (Heisby et 
al., 1997). The phytochemical sulforaphane, an aliphatic isothiocyanate 
from broccoli (Zhang et at., 1992), is a potent monofunctional inducer of 
phase II detoxifying enzymes and an inhibitor of DMBA-induced mammary 
carcinogenesis in rats (Zhang et al., 1994). Sulforamate, a novel analogue 
of sulforaphane, is a monofunctional inducer of QR and GST (Gerhauser et 
al., 1997). However, other chemopreventive agents such as indole-3­4 
Flavanone
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Figure 2: Chemical structure of hop flavanones. 5 
carbinol and phenethyl isothiocyanate are bifunctional inducers in that they 
induce both phase I (CYP1A1) and phase II enzymes (Manson et al., 1997). 
Another compound, brassinin, an indole-based dithiocarbamate found in 
cruciferous vegetables (e.g. Chinese cabbage), is a bifunctional inducer but 
still has significant chemopreventive activities. This compound inhibited 
carcinogen-induced lesion formation in a mouse mammary organ culture, 
reduced the formation of DMBA/phorbol ester-induced papillomas in the 
mouse skin carcinogenesis model, and prevented chemically-induced 
mammary tumor formation in rats (Mehta et al., 1994; Mehta et al., 1995). 
The major objective of this study was to examine the hypothesis that 
flavonoids, prenylated chalcones and flavanones from hops are inducers of 
phase II enzymes such as QR and GST in vivo and in vitro but not of 
CYP1A enzymes. The occurrence of different types of flavonoids with 
prenyl or geranyl group in hops makes it possible to examine structure-
activity relationships in the induction of phase I and phase II enzymes by 
flavonoids.  If some of these hop compounds were found to be 
monofunctional inducers of phase II enzymes, they could be potentially 
useful in the prevention of cancer in humans. 6 
LITERATURE REVIEW
 
Flavonoids. Flavonoids may have existed in nature for over a billion years 
(Swain, 1975). The very long association of plant flavonoids with various 
animal species and other organisms throughout evolution may account for 
the extraordinary range of biochemical and pharmacological activities of 
these chemicals in mammalian and other cell systems. Flavonoids have 
important  effects  in  plant  biochemistry and  physiology,  acting  as 
antioxidants, enzyme inhibitors, precursors of toxic substances, pigments 
and light screens (Harbom and Marby, 1982; McClure, 1986). In addition, 
these compounds are  involved  in  photosensensitization and energy 
transfer, the action of plant growth hormones and growth regulation. 
Further,  these compounds may control  respiration,  photosynthesis, 
morphogenesis, sex determination, and defense against infection (Smith 
and Banks, 1986).  Flavonoids also have several other biological effects 
including  antiallergic,  anti-inflammatory,  antiviral,  antioxidant  and 
antiproliferative properties (Gabor, 1979; Cody et a/.,1988). 
Flavonoids are polyphenolic compounds that occur in many edible 
plants. They are a group of synthetic and naturally-occurring  plant 
compounds that include flavones (synthetic 0-naphthoflavone), isoflavones 
(genistein and biochanin A), flavonols (quercetin), flavanols (catechins in 
tea), and flavanones (naringenin in grapefruit). These compounds differ in 
the level of oxidation of the flavane nucleus and in the number and position 
of the hydroxyl and methoxyl substituents (Lee et al., 1994). Chalcones are 
open C-ring flavonoids in which the two aromatic rings are joined by a 
three-carbon a,13-unsaturated carbonyl system (Bohm, 1994). The average 
flavonoid intake by humans has recently been estimated to be 23 mg per 
day per adult (Hertog et al., 1993). 
The cones from the hop plant, Humulus lupulus, contain  six 
chalcones [xanthohumol (XN), 2',4',6',4-tetrahydroxy-3'-C-geranylchalcone 7 
5 
(TG), dehydrocycloxanthohumol (DX), dehydrocycloxanthohumol hydrate 
(DH),  2',4',6',4-tetrahydroxy-3'-C-prenylchalcone  (TP),  and 
prenylxanthohumol (PX)] (Figure 1) and four flavanones [isoxanthohumol 
(IX), 6-prenylnaringenin (6PN), 8-prenylnaringenin (8PN) (Stevens et at., 
1997),  and  6,8-diprenylnaringenin  (DPN)  (Stevens  and  Deinzer, 
unpublished data)] (Figure 2).  Eleven varieties of hops have been 
examined and in all varieties, XN is the primary flavonoid component (about 
80% of total flavonoids). according to Stevens et al., 1998, a total of six 
prenylflavonoids  ranged from  0.04  to  4.0  mg/I  in  hopped  beers. 
lsoxanthohumol, which formed by isomerization of xanthohumol during 
brewing process, is the most abundant prenylflavonoid in beer (Stevens et 
a1.,1998). The concentration of flavonoids in beer varies with the brand. For 
instance, the concentration of XN in Bachelor Bitter, Budweiser and Miller 
Genuine Draft is 0.12, 0.05 and 0.01 mg per liter, respectively, while IX 
concentration is 1.9, 0.70 and 0.01 mg per liter, respectively (Stevens et 
al.,1999). 
Flavonoids in Cancer Chemoprevention. There is a growing interest in 
flavonoids as cancer chemopreventive agents.  Cancer chemoprevention 
refers to the prevention of cancer in human populations by ingestion of 
chemical  agents  that  prevent  carcinogenesis  (Pezzuto,  1995). 
Chemopreventive agents can be classified as inhibitors of carcinogen 
formation (ascorbic acid, tocopherols, phenolic compounds), inhibitors of 
initiation (phenols, flavones, antioxidants), and inhibitors of post-initiation 
events (tamoxifen, retinoids, terpenes).  On the other hand, Wattenberg 
(1985)  classified phytochemicals with anticarcinogenic properties as:  (1) 
blocking or  anti-initiation  agents and  (2)  suppressing or anti-tumor 
promoting agents. Several mechanisms have been proposed for agents 
which block the initiation of carcinogenesis (Wattenberg, 1985; Morse and 
Stoner,  1993). These include  the  scavenging  of free  radicals  by 8 
antioxidants, the modulation of phase I cytochrome P450 enzymes involved 
in the metabolic activation of many carcinogens, induction of phase II 
detoxifying enzymes and induction of DNA repair. 
Scavenging of Free Radicals by Antioxidants.  Oxidative damage to 
DNA by reactive oxygen species has been proposed to contribute to the 
development of cancer.  Reactive oxygen species are generated from 
various sources (Kehrer and Smith, 1994).  Intracellular pathways such as 
mitochondria!  transport,  mixed-function  oxidation,  metal  ion-catalyzed 
reactions and arachidonic metabolism may directly or indirectly contribute to 
free  radical  production  (Simonian and Coyle,  1996).  Redox active 
compounds such as quinones and quinone intermediates of carcinogenic 
polycyclic aromatic hydrocarbons also generate superoxide anion radicals. 
The superoxide anion can be transformed by complex secondary reactions 
to more reactive hydroxyl radical and other reactive oxygen species. 
There are several cellular defenses against reactive oxygen species 
(Frei, 1994; Halliwell, 1994; Sies, 1993). However, endogenous antioxidant 
defenses  (superoxide  dismutase,  catalase,  glutathione  peroxidase, 
glutathione  transferases  and  metal-binding  proteins  such  as 
metallothionein) may be inadequate to prevent damage from free radicals. 
Dietary antioxidants such as alpha-tocopherol, ascorbic acid and flavonoids 
may play an important role in protecting the cells from reactive oxygen 
species. Flavones, isoflavones and flavanones have been shown to act as 
antioxidants against peroxyl and hydroxyl radicals (Cao et al., 1997). The 
flavonoids, rutin and quercetin are scavengers of superoxide anions (Robok 
and Gryglewski, 1988). The flavonoids may act as hydrogen-donating free 
radical scavengers (Rice-Evans et al., 1996). 
Aside from acting as antioxidants, flavonoids such as genistein may 
also modulate the expression of antioxidant enzymes such as catalase, 
superoxide dismutase and glutathione peroxidase (Sanz et al., 1994; Cai 9 
and Wei, 1996) and antioxidant proteins like metallothionein (Kuo et al., 
1998). Induction of antioxidant enzymes and proteins may help protect the 
cells against oxidative stress, an imbalance between free radical production 
and cellular defense against them (Sies, 1993). Flavonoids with antioxidant 
properties can enhance cellular defenses against reactive oxygen species. 
Modulation of Phase I Cytochrome P450 Enzymes. Cytochrome P450 
enzymes catalyze the oxidation of a wide variety of drugs, pesticides, 
carcinogens, toxicants, pollutants, and ingested natural products as well as 
endogenous compounds such as steroids, fatty acids, fat-soluble vitamins, 
and eicosanoids (Guengerich, 1989). The P450s such as CYPIA,  are 
involved in both the detoxification of carcinogens and in the production of 
ultimate carcinogens. Thus, induction of CYPIA by a chemical is a likely 
indicator of carcinogenicity (lonnides and Park, 1993).  All mammalian 
species apparently possess two inducible CYPIA  enzymes, namely 
CYP1A1 and CYP1A2. Human liver contains relatively high amounts of 
CYP1A2 (42 ± 23 pmol per mg protein) than CYP1A1. In contrast, levels 
of CYP1A1 are higher than CYPIA2 in rodents liver. CYPIA2 is detectable 
in lung, intestine, skin, lymphocytes, and placenta, particularly in tissues 
from cigarette smokers. In addition to cigarette smoke, charcoal-broiled 
meat (a source of polycyclic aromatic hydrocarbon), cruciferous vegetables 
(a source of various indoles), and omeprazole can induce CYPIA enzymes. 
CYP1A1  and  CYP1A2  both  catalyze  the  0-dealkylation  of  7­
methoxyresorufin and 7-ethoxyresorufin. Reactions preferred by CYP1A1 
include  the  hydroxylation  and  epoxidation  of  polycyclic  aromatic 
hydrocarbons such as benzo[a]pyrene, leading to the formation of highly 
reactive metabolites. CYP1A2 catalyzes the N-hydroxylation of aromatic 
amines, such as 4-aminobiphenyl and 2-aminonaphthalene, which in many 
cases is the initial step in the conversion of aromatic amines to tumorigenic 
metabolites.  Both of these enzymes are inhibited by a-naphthoflavone 10 
(Parkinson, 1996). 
Inhibition of P450 activities involved in carcinogen activation has 
been considered relevant in cancer chemoprevention. Polyhydroxylated 
flavonoids such as quercetin, kaempferol, and naringenin were found to 
inhibit the in vitro activation of aflatoxin B1, by inhibiting liver CYP3A4, 
which is the major catalyst in aflatoxin B1 activation in humans (Guengerich 
and Kim, 1990). 
Induction of Phase 11 Detoxifying Enzymes.  Induction of phase II 
enzymes accounts for many of the protective actions of diverse agents that 
block tumor initiation (Kansler et al., 1993). Phase II enzymes involved in 
the detoxification of carcinogens include glutathione S-transferases (GST), 
UDP-glucuronosyltransferase (UGT) and NADPH:quinone reductase (QR). 
The phase  enzymes enhance elimination of carcinogens and then 11 
reactive metabolites from the body by the process of conjugation. 
Glutathione S-Transferases (GST). GST catalyzes the conjugation of 
glutathione (a tripeptide consisting of glycine, cysteine and glutamate) with 
electrophilic compounds (Parkinson, 1996). Glutathione conjugates are 
metabolized further by cleavage to glutamate and glycine residues, followed 
by N-acetylation of resulting cysteine conjugates to produce mercapturic 
acid (Habig et al., 1974). Ninety five percent of this enzyme is found in the 
cytoplasm (soluble GST) and five percent in the endoplasmic reticulum 
(microsomal GST), with higher concentrations in  liver, intestine, kidney, 
testis, adrenal and lung. GST can be divided into four classes, A(a), M(g), 
T(0) and P(E), which have different catalytic activities and specific activities. 
All four classes have a  molecular weight of 45,000 daltons and are 
dissociable into subunits of 25,000 daltons. The subunit composition of 
these classes depend on the species and the organ. For example, GST 
activity in female NJ mouse liver was expressed by four g subunits, two a 
subunits and one Tr subunit (Hu et al., 1996). 11 
UDP-Glucuronosyltransferases (UGT).  UGTs are a family of 
enzymes that catalyze the covalent addition of glucuronic acid to lipophilic 
exogenous and endogenous compounds generating more polar products 
(Meech and Mackenzie, 1997).  There are at least 110 distinct UGT 
cDNAs /genes assigned to 33 families (Mackenzie et al., 1997).  Several 
human UGTs have been cloned, two of which (UGT2B15 and UGT2B17) 
are expressed in prostate cancer LNCaP cell line and can catalyze the 
glucuronidation of dihydrotestosterone (Belanger et al., 1998). Modulation 
of the expression of these two UGTs may be one approach in controlling 
the growth of the androgen-sensitive LNCaP cells. 
The activity of UGTs can be modulated by several dietary factors 
(Miners and Mackenzie, 1991). Sun et al. (1998) have found that biochanin 
A increases UDP-glucuronosyltransferase (UGT) activity and decreases 
PSA production in LNCaP cells. These authors concluded that increased 
conjugation of testosterone with UDP-glucuronic acid catalyzed by UGT 
may be a mechanism for the prevention of prostate cancer. 
NADPH:quinone reductase (QR). NAD(P)H-quinone oxidoreductase 
also called DT:diaphorase (QR; EC 1.6.99.2) is a major phase II enzyme 
found in cytosol. QR catalyses the two electron reduction of quinones and 
quinoinimines using NAD(P)H as electron donors (Ernster, 1987; Riley and 
Workman, 1992). Two electron reduction of quinones protects the cell 
against the toxic and neoplastic effects of free radicals and reactive oxygen 
species arising from one electron reduction (Rongbao et al., 1995). Other 
substrates for this enzyme are potentially toxic compounds, including 
quinone epoxides, azo dyes and C-nitroso derivatives of arylamines (Merk 
and  Jugert,  1991).  The  toxicity  of  quinones,  including  certain 
chemotherapeutic agents such as doxorubicin, have been related to the 
enzymatic or nonenzymatic formation of the corresponding semiquinones 
and their subsequent reaction with molecular oxygen yielding superoxide 
anion  radicals  by spontaneous regeneration  of the quinones.  This 12 
semiquinone redox cycling is prevented by the NAD(P)H:quinone reductase 
because it mediates a 2-electron reduction resulting in the formation of 
hydroquinones instead of semiquinones (Figure 3). Interestingly, inducers 
of this enzyme such as butylated hydroxytoluene, protect against the 
severe ulceration of accidental infiltration of doxorubicin into the area 
around the intravenous infusion (Merk and Jugert, 1991). 
QR is a dimer with two equal subunits of 27 kDa each containing 273 
amino acids and a flavin adenine dinucleotide (FAD) prosthetic  group 
(Parkinson,  1996). The FAD prosthetic group  in  each  subunit  is 
noncovalently attached but remains bound during catalytic cycling; NADH 
or NADPH cycle in and out of the enzyme and must be released from the 
enzyme before substrate can be bound (Prochaska, 1988). The 3-D 
structure of mouse QR in the presence of FAD has been determined in two 
crystal forms by X-ray diffraction methods (Rongbao et al., 1995). Mouse, 
rat and human appear to possess two, three, and four forms of QR, 
respectively (Riley and Workman, 1992). 
QR activity has been measured in normal and tumorous human 
tissues. Normal tissue QR was high in the stomach and kidney, and lower 
in the lung, liver, colon and breast. Primary tumors from lung, liver, colon 
and breast had elevated levels of QR compared to normal tissue, while 
tumor from kidney and stomach had lower levels. A major determinant of 
the variability of human lung tumor QR was the cigarette-smoking history of 
the donor. Non-smokers and past smokers had high levels of tumor QR 
compared to normal tissue. Smokers had levels of tumor QR that were not 
significantly different from those of normal tissue QR. Smokers had a small 
increase in normal lung QR compared to non-smokers. Alcohol use was 
associated with an increase in lung tumor QR, but had no effect on QR in 
normal lung (Schlager and Powis, 1990). Recently, the basal activity of QR 
in the epidermis of mice has been of shown to be very high, comparable to 
that of liver. These results also suggest that the same cytosolic enzymatic 13 
Figure 3: Two-electron reduction of menadione to a hydroquinone, and 
production of reactive oxygen species during the one-electron reduction to 
a semiquinine radical (Rozman and Klaassen,1996) 14 
form is present in liver and skin, in both murine and human tissues. The 
human gene of the QR is localized on chromosome 16 and has been 
cloned as has gene of the murine liver QR (Merk and Jugert, 1991). 
Two forms of human QR have been cloned (Jaiswal, 1994; Joseph 
et al., 1994) and they are designated NAD(P)H:quinone oxidoreductase 1 
(NQ01) and NAD(P)H:quinone oxidoreductase 2 (NQO2). NQO2 is 43 
amino acids shorter than the NQ01 protein. TCDD treatment of human 
hepatoblastoma HepG2 cells leads to an increase of NQ01 mRNA but not 
of NQO2 mRNA (Jaiswal et al., 1990). NQ01 is expressed in all human 
tissues whereas NQO2 has limited tissue distribution and is found in heart, 
brain, lung and liver (Jaiswal, 1994).  Both NQ01 and NQO2 are highly 
polymorphic (Jaiswal et al., 1990; Traver et al., 1992). Polymorphism in 
NQ01 gene results in different levels of expression of QR activity in 
different human tumors (Traver et al., 1992). Polymorphism at nucleotide 
position 609 (C -T, pro>ser) in NQ01 could lead to diminished or absent 
enzyme activity (Ross et al., 1996; Steiner et al., 1999). Three alleles of the 
NQ01 gene have been identified in the human population: a functional 
Arg139/Pro187 (NQ01*1), nonfunctional Arg139/Ser187 (NQ01*2), and a 
TRP139/Pro187 (NQ01*3) associated with diminished enzyme activity 
(Gaedigk et al., 1998). 
The upstream region of the human QR gene contains a xenobiotic 
response element (XRE), an antioxidant responsive element (ARE) and an 
overlapping  12-0-tetradecanoyl-phorbol-13-acetate  response  element 
(TRE). (Wang and Williamson, 1996).  Bifunctional inducers (inducers of 
phase  and phase II enzymes) activate both the XRE and ARE. The I 
induction of NQO1 by BNF and BHA require the presence of an AP1 
binding site contained within the ARE and are mediated by products of 
proto-oncogenes, Jun and Fos (Belinsky and Jaiswal, 1993).  Induction of 
QR by monofunctional inducers (redox cycling phenolics such as catechols 
and hydroquinone) is via the ARE and not the TRE, suggesting that 15 
induction is mediated by proteins other than Jun and Fos (Wang and 
Williamson, 1996). ARE, which contains three AP1/AP1-like elements and 
a GCA box, is the most important cis-element required for basal expression 
and for induction of NQ01 gene (Joseph et al., 1994). Montano et al. (1998) 
have reported that antiestrogens, in the presence of a functional estrogen 
receptor, stimulate human QR by stimulating the activity of the QR  gene 
promoter which contains the electrophile/antioxidant response element.  In 
addition to the ARE and XRE, the NQ01 gene promoter also contains 
another cis-element, AP-2,  that  regulates  basal and cAMP-induced 
transcription of the QR gene (Xie and Jaiswal, 1996).  The nuclear 
transcription factors, Nril and Nrf2, bind to the ARE and upregulate ARE-
mediated gene expression of NQ01 whereas other nuclear transcription 
factors such as c-Fos and Fra1 which bind to ARE negatively regulate 
NQ01 gene expression (Venugopal and Jaiswal, 1996). 
QR is inducible up to tenfold by monofunctional and bifunctional 
inducers (Prochaska and Talalay, 1992). The effects of bifunctional and 
monofunctional agents are mediated by two different responsive regulatory 
DNA sequences in the 6-region of the QR gene (Favreau and Pickett, 
1991; Rushmore et al., 1991). One mechanism of induction of NQO1  gene 
expression involves transfer of a redox signal from antibiotics to unknown 
"redox protein(s)" which in turn, modify the Jun and Fos proteins for greater 
affinity towards the AP1 site contained with the ARE of the NQ01 gene and 
activates transcription (Belinsky and Jaiswal, 1993). 
Effects of Phytochemicals on Phase  II  Enzymes.  Induction  of 
carcinogen-detoxifying (phase II) enzymes represents a major mechanism 
by which phytochemicals can act as cancer chemopreventive agents. 
Sulforaphane (an aliphatic isothiocyanate) and brassinin (an indole-based 
dithiocarbamate found in cruciferous vegetables) are inducers of phase II 
enzymes (Gerhauser et  al.,  1997; Zhang et  al.,  1994). A novel 16 
chemopreventive agent, 4-methylsulfony1-1-(S-methildithiocarbamy1)-butane 
(known as sulforamate), an aliphatic analogue of brassinin with structrural 
similarities to sulforaphane, is also capable to inducing QR in murine Hepa 
1c1c7 cells (Gerhauser et at., 1997). A study carried out with naturally 
occurring  organosulfides from  garlic  indicated  that chemopreventive 
efficacy is correlated with their ability to increase the expression of GST P 
(Hu et al., 1996). A polyphenolic fraction from green tea, when given orally 
to mice, produced an enhancement of GST and QR in small bowel and liver 
(Khan et al., 1992). Certain chalcones have recently been found to induce 
GST and QR in mouse hepatoma 1c1c7 and rat hepatoma H4IIE cells 
(Song et at., 1997). Genistein, an isoflavone from soybeans, is also  an 
inducer of QR in mouse Hepa 1c1c7 cells (Yannai et al., 1998). Relatively 
few studies have investigated the influence of isoflavonoids on carcinogen-
detoxifying enzymes despite the observation that diets high in soy content, 
rich in isoflavonoids, have been associated with a relatively low incidence of 
breast and prostate cancer in humans (Messina et al., 1994, Adlercreutz et 
al., 1995). 
Phytochemicals could be monofunctional or bifunctional inducers of 
drug-metabolizing enzymes (Prochaska and Talalay, 1988; Talalay, 1992). 
Monofunctional agents induce the phase 11 enzymes such GST and UDPGT 
which enhance elimination of carcinogens from the body without inducing 
phase I enzymes. The bifunctional agents induce both phase I and phase II 
enzymes. Induction of the phase I  enzyme, CYP1A1, usually enhances 
chemical carcinogenesis due to production of reactive metabolites. 
Sulforaphane, an ingredient of broccoli acts as a monofunctional 
inducer of QR via the antioxidant responsive element (ARE), whereas 6­
naphthoflavone (BNF) induces QR by both mechanisms. BNF (parent 
compound) binds to the Ah receptor which is responsible for inducing QR 
via a xenobiotic responsive element (XRE) and  metabolites of BNF are 
responsible for inducing QR via the ARE. 17 
MATERIALS AND METHODS 
Materials 
Culture media (D-MEM/F-12) and fetal bovine serum (FBS) were 
obtained from Gibco (Grand Island, NY). Ninety-six-well plates were 
purchased from Costar Corporation, (Cambridge, MA). Tissue culture 
flasks (75-cm2)  used were manufactured by Nalge (Nunc International, 
Denmark).  Digitonin,  unlabeled  testosterone,  trypsin,  penicillin  and 
streptomycin were obtained from Sigma Chemicals (St. Lauis, MO). Sodium 
dodecyl sulfate and nitrocellulose (0.4mm, Trans-Blot) were obtained from 
Bio-Rad, Richmond, CA. Coomassie Plus protein assay reagent was from 
Pierce (Rockford, IL). [1251]-Protein A and ([3H]-1,2,6,7)-testosterone were 
from ICN (Irvine, CA) and New England Nuclear (Boston, MA), respectively. 
Flavonoid compounds were obtained from Dr. Fred Stevens and Dr. Max L. 
Deinzer, Department of Chemistry, Oregon State University. 
Cell culture and Treatments 
Mouse Hepa 1c1c7 cells were obtained from Dr. James Whitlock, 
Department of Pharmacology, Stanford University, Stanford CA. Rat H4IIE 
and human LNCaP prostate cancer cells were obtained from the American 
Type Culture Collection (Manassas, VA) and initially the cells were grown in 
200-m1 (75-cm2) flasks  for 3-4 days. Cells were trypsinized and counted 
using a Coulter Counter manufactured by Coulter Electronics, Hialeah, 
Florida. About 1500 cells were transferred to each well of ninety-six-well 
plates, with each well containing 200 µl of culture media.  Culture media 
consisted of D-MEM/F/12, 5% fetal bovine serum, 100 unit/ml of penicillin 18 
and 100 p.g /ml streptomycin. Cells were incubated at 37°C in a water 
saturated atmosphere containing 5% CO2. Cultures were allowed to grow in 
the plates for two days prior to the treatments. Cells were treated with 0.1, 
1, 5, 10 and 100 liM concentrations of XN, IX, DH, DX, 6PN, 8PN, TG, TP, 
PX, DPN along with other compounds such as biochanin A (BA), 0­
naphthoflavone (BNF), butylated hydroxyanisole (BHA), naringenin (NG), 
genistein  (GS),  resveratrol  (RV),  tetrahydroxanthohumol  (TX), 
chalconaringenin (CN); xanthogalenol (XG), 5'diprenylxanthohumol (DPX) 
and 7,12-dimethylbenz[a]anthracene (DMBA). Since all the flavonoids and 
other compounds were dissolved 100% ethanol, control cells were fed 
media containing 0.1% ethanol. After two and four days of treatment, the 
culture media were aspirated and the cells in each well were lysed with 50 
I.LI of a solution containing 0.8 % digitonin and 2mM EDTA (Prochaska and 
Santamaria, 1988) for the determination of QR activity and protein content. 
Alternatively, the cells were fixed with 10% trichloroacetic acid (TCA) for 
staining with sulforhodamine. 
Animal experiments 
Mouse experiments.  The objectives of the mouse study were to (1) 
determine if XN modulate the expression and catalytic activities of different 
forms of cytochrome P450 (CYP1A1, CYP1A2, CYP1B1, CYP2E1 and 
CYP2B1 and CYP3A) in mouse liver; (2) determine the induction of QR, 
GST and GSH by XN and IX in mouse liver; and (3) determine the 
hepatotoxic effects of XN and IX in vivo. To achieve these goals, 7-week 
female CD-1 mice, obtained from Charles River Breeding Laboratories 
(Wilmington, MA), were divided into 6 groups of 6 animals and treated as 
follows: 19 
Experiment 1 (gavage)  Experiment 2 (i.p.) 
Group 1.  Untreated controls.  Vehicle control (sesame oil). 
Group 2.  Vehicle control (sesame oil).  XN, 5 mg/kg. 
Group 3.  XN, 5 mg/kg.  XN, 25 mg/kg. 
Group 4.  XN, 25 mg/kg.  IX, 5 mg/kg. 
Group 5.  IX, 5 mg/kg.  IX, 25 mg/kg. 
Group 6.  IX, 25 mg/kg.  BNF, 5 mg/kg. 
The mice were gavaged or i.p. treated with sesame oil, BNF or the test 
compounds (in sesame oil) for 4 consecutive days at a dose of 10 RI/g of 
mouse. The animals were killed by inhalation of carbon dioxide 24 hr after 
the last treatment. Heparinized blood was collected and liver, kidney, small 
intestine and stomach were removed and used for various assays. Organs 
such as liver, kidney, stomach, intestine were removed and stored at 80 
°C until use. 
Preparation of Homogenates, Microsomes and Cytosol 
Livers, kidneys, stomachs and intestines were homogenized in four 
volumes of 0.1 M Tris-acetate buffer (pH 7.5) containing 0.1 M KCI and 1 
mM EDTA. The homogenate was then centrifuged at 10,000 x g for 30 
minutes. The post mitochondrial supernatant was centrifuged further at 
105,000xg for 90 minutes. The microsomal pellet was resuspended in a 
buffer containing 10 mM Tris-acetate (pH 7.4), 0.1M EDTA, and 20% 
glycerol. The homogenates, microsomes and cytosol was then stored 
at 80°C until use. 20 
Protein assay 
Protein content of cell lysate in each well and subcellular fractions of 
mouse tissues was determined using Coomassie Plus protein assay 
reagent. Appropriate aliquots of these samples were transferred to 96-well 
plates, and 200 pi of protein reagent was added to each sample. Bovine 
serum albumin was used to generate the standard curve. Absorbance at 
595 nm and corresponding protein concentrations were determined with a 
SpectraMAX 250 microplate spectrophotometer manufactured by Molecular 
Devices Ltd., Crawley, UK. 
Sulforhodamine assay 
Sulforhodamine (SRB) assay was performed as described by 
Skehan et al. (1990). Cell cultures treated with hop flavonoids and other 
compounds were fixed with trichloroacetic acid (TCA) on day 2 and day 4. 
After aspiration of culture media, the cells were incubated with 10% TCA for 
1 hr at 4°C and then washed five times with tap water to remove TCA. 
Plates were air-dried and then stained for 30 min with 0.4% (w/v) SRB 
dissolved in 1% acetic acid. SRB was removed and cultures were quickly 
rinsed four times with 1% acetic acid to remove unbound dye.  Residual 
wash solution was removed and the cultures were air-dried. The bound dye 
was then solubilized with 200 1.1.1 of 10 mM unbuffered Tris base (pH 10.5). 
The absorbance of each well at 564 nm was read in a SpectraMAX 250 
microplate spectrophotometer (Molecular Devices, Menlo Park,  CA). 
Cytotoxicity was calculated from the ratio of the absorbance readings of the 
treated wells to those of the control wells. 21 
Glutathione S-transferases assay. 
GST activity was determined according to Habig et al. (1974). Stock 
solutions of 14.3 mM glutathione (GSH) in 10 mM potassium phosphate 
buffer at pH 6.5 and 50 mM 1-chloro-2-4-dinitrobenzene (CDNB) in 
dimethylsulfoxide (DMSO) was prepaired fresh. Reaction mixture containing 
0.8 ml of 125 mM potassium phosphate buffer at pH 6.5, 0.07 ml of GSH in 
12.5 mM potassium phosphate buffer, 0.02 ml CDNB, and 0.09 ml of water. 
Fifty ml aliquots of lysed cells or fifty times diluted cytosol from animal 
experiments were transferred into each well of new ninety-six well plates, 
and 200 ml of assay mixture was added to each well. OD at 340 nm was 
recorded every minute for ten minutes using a SpectraMAX 250 microplate 
spectrophotometer.  The increase in OD at 25°C during the first three 
minutes was used for calculation of GST activity. 
Quinone reductase assay 
QR activity was determined according to Prochaska and Santamaria 
(1988). In this assay, QR will catalyze the reduction of menadione to 
menadiol by NADPH, and MU is reduced nonenzymatically by menadiol 
resulting in a blue color. The rate of change of the blue color intensity is 
determined by the activity of QR in the sample (Figure 4). The reaction 
mixture consisted of an NADPH generating system, menadione and MU 
(3[4,5-dimethylthiazo-2-y1]-2,5 -diphenyltetrazolium  bromide). The assay 
mixture was prepared as follows: 0.75 ml of 0.5 M Tris-HCI (pH 7.4), 10 mg 
bovine serum albumin, 0.1 ml of 1.5% Tween 20, 0.01 ml of 7.5 mM FAD, 
0.1 ml of 150 mM glucose-6-phosphate, 9µl of 50 mM NADP+, 30 units of 
yeast glucose-6-phosphate dehydrogenase, 4.5 mg of MU, and distilled 
water to a final volume of 15 ml. Menadione (1 ill of 50 mM menadione 22 
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Figure 4: Principle of the assay of quinone reductase as described by
Prochaska and Santamaria, 1988. 
dissolved in acetonitrile per ml of reaction mixture) was added to the 
mixture immediately before use.  Fifty gl aliquots of lysed cells were 
transferred into each well of new ninety-six well plates, and 200 11,1 of assay 
mixture was added to each well. OD at 610 nm was recorded every three 
minutes  for  twelve  minutes  using  a  SpectraMAX 250  microplate 
spectrophotometer. The increase in OD at 25°C during the first six minutes 
was used for calculation of QR activity. The proportion of MTT reduction 
attributable to quinone reductase activity was determined by incubating 
lysed cells in assay buffer with 50 µl per well of 0.3 mM dicoumarol in 0.5% 
DMSO and 5 mM potassium phosphate (pH 7.4). 23 
Western blotting 
Cells were grown in six-well culture plates in order to get higher 
concentration of protein per unit volume. Cultures were washed with 
phosphate buffer saline (PBS) at pH 7.4 and scraped with a rubber 
policeman in 0.1 M potassium phosphate buffer (pH 7.4) containing 1 mM 
EDTA, 30% glycerol, 1 mM DTT and 0.1 mM PMSF buffer. The cells were 
stored at 80°C until use. Sodium dedocyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) was performed according to Laemmli (1970). 
Running gel and stacking  gel  contained 10% and 4% acrylamide, 
respectively. Microsomes or cell samples were prepared in loading buffer 
consist of 0.5 ml of 1 M Tris-HCI (pH 6.8), 1.6 ml of 10% SDS, 1.6 ml of 
glycerol, 0.2 ml of 0.1% pyronin Y, 0.4 ml of [3-mercaptoethanol and distilled 
water in a final volume of 8 ml. Each lane was loaded with 15 µg of protein 
in 15 pi of loading buffer. Gels were run at 150 volt until the dye reached the 
bottom of the gels. Kaleidoscope Prestained Standards (manufactured by 
Bio-Rad  Laboratories,  Hercules,  CA)  used  for  molecular  weight 
determination were bovine serum albumin (71,000), carbonic anhydrase 
(41,800), soybean trypsin  inhibitor  (30,600),  lysozyme (17,800) and 
aprotinin (6,900). 
The separated proteins were electroblotted to a nitrocellulose using 
10 volts for 1 hour. The blots were incubated in 5% bovine serum albumin 
(BSA) in TBS-T (20 mM Tris-HCI, pH 7.8, 0.5 M NaCI, 0.05% Tween 20) for 
1 hour to block  nonspecific binding. The membrane was then incubated 
with a solution of rabbit antibodies raised against rat CYP1A1 containing 20 
mg of IgG per ml in 2% BSA in TBS-T for 1 hour at room temperature. The 
membrane was washed  4 times with TBS-T (5 minutes each) and 
incubated with [125I]-protein A for 1 hour. It was washed 4 times again with 
TBS-T to remove unbound 1251. The membrane was air dried for 2-3 
minutes and wrapped in a transparent plastic paper to keep moist. It was 24 
then exposed to a Kodak film (manufactured by Eastman Kodak Company, 
Rochester, NY) for 24 hours.  Immunoquantification were performed by 
scanning the autoradiography on a Molecular Dynamics densitometer. To 
verify completeness of transfer of proteins to nitrocellulose, the gels left 
from the transfer were stained in 0.15% Coomassie brilliant blue, 30% 
methanol, 10% acetic acid overnight at room temperature and destained in 
40% methanol and 10% acetic acid. 
Inhibition constant (IC50) calculation 
Experiments were conducted to calculate dosage producing 50% 
inhibition of cell growth  (IC50). XN, IX and DH were used as test 
compounds. Mouse 1c1c7 and rat H4IIE cells were treated with doses of 2, 
4, 6, 8, 10, 12, 14, 16 and 18 1.1M concentration of hop compounds. Cultures 
were terminated with 10% TCA and SRB staining was performed as 
described above. 
Statistical analysis 
Reported values are the means and standard error from the 
observations. Means were compared by analysis of variance and Student's 
t-test and differences were considered statistically significant at p<0.025. All 
data was analyzed with the statistical package Sigma Plot Version 4.0. 25 
RESULTS
 
Induction of QR in mouse hepa 1c1c7 cells 
Six chalcones (XN, TP, TG, DX, DH and PX) and four flavanones 
(IX, 6PN, 8PN and DPN) from hops were examined for their potency 
(concentration required to produce half-maximal response) and efficacy 
(maximal induction level) to induce QR activity in mouse Hepa 1c1c7 cells 
after 2 days of treatment.  In addition, other flavonoids (BNF, BC, GS and 
NG) and inducers of QR such as RV and BHA were also tested for their 
ability to induce QR in this cell line. At 0.1 1AM, only DX and DPN from hops 
produced a significant increase in QR activity (Figure 5; Table 1). At 1 p,M, 
XN, DH, DX, PX and DPN increased QR activity by 74%, 79%, 82%, 64% 
and 66%, respectively (Figure 6; Table 1). At 5 p.M, most of the flavonoids 
except DPX, IX, 6PN and 8PN significantly increased QR activity, with DH 
and XN being the two most active flavonoids in hops (Figure 7; Table 1). 
When the concentration of the test compounds was increased to 10 I.LM, 
6PN and PX increased and decreased QR activity, respectively (Figure 8; 
Table 1). Maximal induction was observed at 54M for XN (3.28-fold) and at 
10 iiM for DH (5.4-fold) 2 days after treatment. IX, the flavanone isomer of 
XN, caused only 1.3-fold increase in QR activity at 10 Al. 
Exposure of Hepa 1c1c7 cells to the test compounds for 4 days 
resulted in essentially the same pattern of induction as that observed at 2 
days (Figures 5 to 8; Table 1). However, there was a slight decrease in the 
magnitude of induction of QR by DH at 10 p.M (3.3-fold at 4 days compared 
to 5.4-fold at 2 days). In addition, the increase in QR activity by XN at 10M 
was slightly greater at 4 days (3.7-fold) than at 2 days (3.4-fold).  At 250 
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Figure 6: Quinone reductase activity in mouse hepa 1c1c7 cells treated with 1 [LM concentration 
of hop flavonoids and other compounds. QR assays were conducted on day 2 and 4 after 
treatment. Each bar represents the average induction of four replicates. Enzyme activity is 
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Figuer 8: Quinone reductase activity in mouse hepa 1c1 c7 cells treated with 10 IIM concentration
 
of hop flavonoids and other compounds. Each bar represents the avarage induction of four replicates.
 
Enzyme activity is expressed as percent of control (treated with 0.1% of ethanol).  Results are
 
summarized in Table 1. 
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,0 Table 1: Quinone reductase activity in mouse hepa 1c1c7 cells. Percent of control values a. 
COMPOUND  2 DAYS  4 DAYS 
0.1 pM  1.0 p.M  5 AM  1041M  0.1 pM  1.0 1.1M  5 p.M  10 p.M 
Chalcones 
(hops) 
XN  91 ± 0.7  174 ± 1.5*  328 ± 0.9*  321 ± 5.8*  93±4.5  142 ± 2.7*  292 ± 0.9*  373 ± 7.4* 
XG (synthetic)  94 ± 1.5  103 ± 1.8  162 ± 2.4*  207 ± 2.5*  99±2.4  105 ± 2.0  143 ± 2.4  194 ± 3.2* 
TP  104± 1.9  112 ± 0.6  190 ± 1.4*  238 ± 4.8*  119±2.8  134± 1.5  152 ± 1.4*  184 ± 8.4* 
TG  75 ± 0.4*  113 ± 1.4  202 ± 1.8*  236 ± 2.1*  103±4.1  123 ± 1.9  129 ± 1.8  142 ±15.* 
DX  157± 3.4*  182 ± 0.6*  214 ± 0.9*  201 ± 1.7*  120±0.2  153 ± 0.5*  206 ± 0.9*  217 ± 1.8* 
DH  115 ± 1.5  179 ± 1.6*  341 ± 0.8*  541 ± 0.5*  113±4.3  181 ± 1.3*  252 ± 0.9*  333 ± 4.5* 
tTX  106 ± 1.8  134 ± 2.3  187 ± 0.9*  173 ± 2.4*  101±2.0  119 ± 1.8  159 ± 0.9*  203 ± 1.8* 
PX  90 ± 0.6  164 ± 1.4*  197 ± 0.8*  17 ± 0.8*  115±0.5  107 ± 0.5  151 ± 0.8*  0 ± 2.5 
tDPX  100 ± 2.1  112± 1.9  120± 1.5  138 ± 2.4  110±1.5  130± 1.2  149± 1.5*  167 ± 3.1* 
CN (synthetic)  95 ± 1.6  97 ± 1.5  98 ± 1.2  129 ± 1.2  103±1.4  102 ± 2.3  100 ± 1.2  100 ± 2.1 
Flavanones 
(hops) 
IX  80 ± 0.8*  86 ± 0.8*  129 ± 1.2  135 ± 1.4*  84±0.8*  94 ± 5.8  113 ± 1.2  119 ±16 
6PN  137 ± 4.5  132 ± 0.6  135 ± 0.3  179 ± 2.2*  56 ±1.9*  99 ± 0.4  125 ± 0.3  135 ± 0.5* 
8PN  81 ±3.9*  130 ± 1.1  110 ± 0.4  144 ± 1.3*  95±0.2  88 ± 0.4*  90 ±0.4  111 ± 0.6 
DPN  151 ± 3.8*  166 ± 2.4*  207 ± 0.7*  212 ± 2.5*  106±0.5  122 ± 0.5  170 ± 0.7*  212 ± 0.9* 
Continued. Table 1 continued. 
COMPOUND  2 DAYS  4 DAYS 
Flavanone 
0.1 iiM  1.0 piM  5µM  10µM  0.1 tiM  1.0 ptIVI  5µM  10µM 
(grapefruit) 
NG  101 ± 1.5  108 ± 0.3  89 ± 3.2  88 ± 0.9  109 ± 0.5  108 ± 2.4  117 ± 4.1  111  ± 3.5 
Isoflavone 
(soybean) 
GS  108 ± 2.8  104 ± 0.6  124 ± 2.1  137 ± 0.7*  103±2.3  106 ± 3.9  111 ± 2.1  109 ± 2.4 
Flavone 
(synthetic) 
BNF  221  ± 7.1*  661 ± 2.7*  1007± .2*  935 ± 4.2*  167±4.3*  317 ± 5.6*  457 ± 1.2*  593 ± 6.9* 
Stilbene 
(grapes) 
RV  78 ± 2.5*  115 ± 1.4  160 ± 0.3*  135 ± 2.4  131±1.2  113 ± 0.8  118 ± 0.3  143 ± 0.5* 
Other 
BHA  88 ± 2.0  74 ± 0.7*  121  ±2.3  151 ±5.2*  87 ± 2.4  101 ±2.4  100 ± 3.1  94 ± 9.3 
BC  84 ± 0.9*  86 ± 0.5  99 ± 2.9  99 ± 0.7  108 ± 4.1  87 ± 4.3  90 ± 4.1  94 ± 4.0 
DMBA  208 ± 1.4*  23 ± 0.2* 
Values are means ± S.E. for 4 replicates. 
* Significantly different from control, p<0.025. 
aValues are expressed as percent of controls (treated with 0.1% ethanol). 
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100 1AM, the hop flavonoids (XN, IX, TP, TG, DH) significantly decreased 
QR activity whereas BNF, BHA and BC induced OR after 2 or 4 days of 
treatment (Figure 9). NG (a flavanone from grapefruit) failed to induce QR 
activity at any of the concentrations used. GS (an isoflavone from 
soybeans) significantly induced QR activity (37% increase over controls) 
only at 10 µM after 2 days after treatment.  At 10  BNF (a synthetic 
flavone) was the most potent inducer of QR in Hepa 1c1c7 cells, increasing 
the enzyme activity 9.35-fold after 2 days and 5.9-fold after 4 days of 
treatment (Figures 5 to 8; Table 1). 
Induction of QR in rat hepatoma H4 IIE cells 
Induction of QR in rat H4IIE cells was relatively low when compared 
with the mouse Hepa 1c1c7 cell line (Figures 10 -13; Table 2). All flavonoid 
compounds from hops were able to induce the activity by 1.1 to 1.6-fold 
over the control after 2 or 4 days of exposure. The highest induction (1.6­
fold) occurred in cells treated with 5 0,4 DH for two days. Most flavonoids 
produced a statistically significant increase in QR activity of rat H4IIE cells 
over the range of doses used. However, XN, at 5 and 10 11M, significantly 
inhibit the QR activity in rat H4IIE cells. XN was cytotoxic to H4IIE cells at 5 
and 10 1.1,M concentration.  In contrast, BNF (10 p,M), the most active 
inducer of QR in this cell line as in Hepa 1c1c7 cells, increased QR activity 
3.5-fold and 2.8-fold after 2 and 4 days of treatment, respectively. GS, an 
inducer of QR in Hepa 1c1c7 cells, failed to increase QR activity in rat 
H4IIE cells. 800
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Figuer 9: Quinone reductase activity in mouse hepa 1c1c7 cells were treated with 100 µM concentration 
hop flavonoids and other compounds. Each bar represents the average induction of four replicates. Enzyme 
activity is expressed as percent of control (treated with 0.1% ethanol).Results  are summarized in Table 1. 150 
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Figuer 10: Quinone reductase activity in rat hepatoma H4IIE cells treated with 0.11AM concentration 
of hop flavonoids and other compounds. Each bar represents the average of four replicates QR assays 
were conducted on day 2 and 4 after treatment. QR activity is expressed as percent of control (treated 
with 0.1% ethanol). Values are presented in Table 2. 300 
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Figure 11: Quinone reductase activity in rat hepatoma H4IIE cells treated with 1.0  .tM 
concentration of hop flavonoids and other compounds. Each bar represents the average of 
four replicates. Enzyme activity is expressed as percent of control (treated with 0.1% ethanol). 
QR assays were performed on day 2 and day 4. Results are summarized in Table 2. 500 
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Figure 12: Quinone reductase activity in rat hepatoma H4IIE cells treated with 5 g_tM 
concentration of hop flavonoids and other compounds. Each bar represents the average 
induction of four replicates. QR activity is expressed as percent of control (treated with 0.1% 
ethanol). Results are summarized in Table 2. 400 
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Figure 13: Quinone reductase activity in rat hepatoma H4IIE cells treated with 10  p.M concentration of hop
flavonoids and other compounds. QR activity is expressed as percent of control (treated with 0.1°/0 ethanol). 
Each bar represents the average activity of four replicates. Summary results  are presented in Table 2. Table 2: Quinone reductase activity in rat H4IIE cells. Percent of control values a. 
COMPOUND  2 DAYS  4 DAYS 
0.1 pM  1.0 Al  5.0 AM  10 gM  0.1 JIM  1.0 p,M  5.0 gM  10 1AM 
Chalcones 
(hops) 
XN  98 ± 2.5  123 ± 4.5*  11 ±1.8*  8 ± 1.3*  92 ± 2.2  96 ± 4.2  23 ± 2.2*  12 ± 1.5* 
XG (synthetic)  99 ± 2.3  100 ± 3.2  112 ± 2.3  121 ± 2.4*  96 ± 2.2  96 ± 4.1  107 ± 2.4  114 ± 3.6 
TP  114 ± 1.1  141 ± 2.8*  144 ± 3.1*  149 ± 2.0*  95 ± 1.5  108 ± 6.2  111 ± 0.9*  114 ± 2.3 
TG  130 ± 1.7*  133 ± 2.3*  130 ± 4.1*  143 ± 5.8*  103± 1.0  117 ± 0.6  109± 1.2  126 ± 9.9* 
DX  133 ± 5.5*  113 ± 1.6  126 ± 1.3*  141 ± 5.1*  113 ± 5.2  109 ± 1.8  141 ± 2.5*  131 ± 2.0* 
DH  119 ± 1.4  133 ± 2.4*  164 ± 4.0*  91 ±2.2  101 ±3.6  98 ± 2.4  116 ± 3.1  105 ± 5.8 
tTX  95 ± 1.5  113 ± 2.5  123 ± 2.6  126 ± 4.3*  100 ± 2.1  114 ± 2.3  123 ± 4.2  138 ± 2.7* 
PX  112 ± 3.1  116 ± 1.8  150 ± 5.6*  47 ± 1.9*  103 ± 3.0  108 ± 1.6  117 ± 5.9  72 ± 10.8* 
1. DPX  98 ±2.1  99± 1.1  104 ±3.2  116±5.2  105±4.2  111 ±2.8  120 ±2.3  119±3.2 
CN (synthetic)  94 ± 2.3  98 ± 3.2  102 ± 3.3  115 ± 5.3  100 ± 3.5  104 ± 2.1  108 ± 4.2  106 ± 4.2 
Flavanones 
(hops) 
IX  103 ± 2.8  105 ± 1.2  115± 1.7  123 ± 2.7*  93 ± 1.4  96 ± 2.3  95 ± 4.4  106 ± 7.3 
6PN  109 ± 3.7  126 ± 3.9  123 ± 1.0  132 ± 2.1*  95 ± 10.0  110 ± 4.6  100 ± 1.6  118 ± 3.8 
8PN  125 ± 8.7  117 ± 2.2  105 ± 1.8  105 ± 2.3  110 ± 4.8  105 ± 1.5  109 ± 2.0  115 ± 5.1 
DPN  82 ± 6.7  124 ± 3.4  128 ± 2.2  135 ± 4.2*  97 ± 2.1  104 ± 3.2  114 ± 4.7  122 ± 2.5* 
Continued. Table 2 continued. 
COMPOUND  2 DAYS  4 DAYS 
0.1 p.M  1.011M  5.0 µM  10 liM  0.1 AI  1.0 p.M  5.0 ii,M  10 INI 
Flavanone 
(grapefruit) 
NG  100 ± 3.5  98 ± 2.1  112 ± 2.1  114 ± 1.2  98 ± 1.85  98± 1.9  113 ±4.2  110 ± 4.4 
Isoflavone 
(soybean) 
GS  99 ± 2.0  117 ± 5.0  102 ± 3.4  86 ± 4.2  95 ± 4.7  91 ± 14.1  94 ± 6.6  104 ± 1.4 
Flavone 
(synthetic) 
BNF  155 ± 4.3*  260 ± 4.5*  442 ± 18.2*  355 ± 6.7*  129 ± 1.4*  198 ± 4.1*  254 ± 6.8*  282 ± 5.2* 
Stilbene 
(grapes) 
RV  118 ± 2.2*  99 ± 1.7  106 ± 1.9  99 ± 1.4  104 ± 11.4  74 ± 7.4  99 ± 5.9  111 ±4.5 
Other 
BHA  115 ± 3.1  114± 1.9  127 ± 5.1*  136 ± 1.7*  106 ± 2.7  110 ± 0.8  123 ± 2.3  134 ± 5.4* 
BC  110 ±4.5  110 ±1.7  140 ±2.1*  108 ±3.1  108 ±2.1  101 ±1.9  116 ± 6.3  103 ± 6.1 
DMBA  193 ± 2.9  202 ± 7.5 
Values are means ± S.E. for 4 replicates. 
* Significantly different from control, p<0.025. 
aValues are expressed as percent of controls (treated with 0.1% ethanol). 
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Induction of QR in human LnCaP cells 
In general, the overall increases in QR activity in LNCaP cells 
exposed to hop flavonoids (Figures 14 to 17; Table 3) were relatively lower 
than in mouse Hepa 1c1c7 cells but slightly higher than in rat H4IIE cells. 
As in Hepa 1c1c7 cells, DH was the most effective flavonoid in inducing QR 
in LNCaP cells. At 10 p.M, DH increased QR activity 2.5-fold after 2 days 
and 2.4-fold after 4 days of treatment. Unlike in Hepa 1c1c7 cells, PX (10 
1.1M) was better than XN (10 4M) in  inducing QR in LNCaP cells. 
Chalconaringenin (CN), a semi-synthetic chalcone from hops with no prenyl 
or 0-methyl substituents, did not induce QR, whereas the flavanone isomer, 
NG (1 or 5 IN), significantly increased QR activity in LNCaP cells after 4 
days of treatment.  In mouse Hepa 1c1c7 cells, NG failed to increase QR 
activity (Table 1).  Xanthogalenol (XG), a synthetic chalcone having a 
chemical structure similar to XN with an 0-methyl substituent at 4' as 
compared to 6' in XN, also is an inducer of QR in LNCaP cells.  IX and RV 
increased QR activity in Hepa 1c1c7 cells but not in LNCaP cells (Table 3). 
Sulforhodamine B assay 
Cytotoxicity studies were conducted using mouse Hepa 1c1c7, rat 
hepatoma H4IIE and human LNCaP prostate cancer cells. Results suggest 
that most of the hop compounds are non-toxic at lower concentrations. 
Also, it was observed that 1c1c7 and H4IIE cells recover rapidly or after the 
second day, but the most compound were continuously toxic to LNCaP 
cells, which cause either more percent of cell death or slow recovery. A 
total of 28.8% of the 1c1c7 cells were killed by 10 p.M XN in 2 days, but it 
was 14% at 4 days, which indicate the rapid recovery. In LnCaP cells, 250 
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Figuer 14: Quinone reductase activity in human prostate cancer cells (LNCaP) treated 
with 0.1 µM concentration of hop flavonoids and other compounds. QR activity is expressed 
as percent of control (treated with 0.1% ethanol). Each bar represents the mean of four 
replicates. Results of the assays are given in table 3.  .4, 600
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Figure 15: Quinone reductase activity in human LNCaP cells treated with 1 firM hop flavonoids and other 
compounds. Enzyme activity is expressed as percent of control (treated with 0.1% ethanol). Each bar 
represents the average activity of four replicates. Results of QR assays are summarized in Table 3. 2 DAYS
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Figure 16: Quinone reductase activity in hunam prostate cancer cells (LNCaP) treated with 5µM concentration 
of hop flavonoids and other compounds. Enzyme activity is expressed  as percent of control (treated with 0.1% 
ethanol). Each bar represents the average of four replicates. Results of QR assay are sumarized in Table 3. 600
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Figure 17: Quinone reductase activity in human prostate cancer cells treated with 10 µM concentration 
of hop flavanoids and other compounds. Enzyme activity is expressed as percent control (treated with 0.1% 
ethanol). Each bar represents the average of four replicates QR assay results are summarized in Table 3. Table 3: Quinone reductase activity in human LNCaP cells. Percent of control values a. 
COMPOUND  2 DAYS  4 DAYS 
0.1 pM  1.0 p,M  5.0 pM  10_pM  0.1 pM  1.0 p,M  5.0 gM  10 1.1.M 
Chalcones 
(hops) 
XN  108 ± 1.5  124 ± 4.1  150 ± 3.3*  104 ± 7.2  102 ± 2.3  123 ± 5.3  192 ± 2.3*  156 ± 4.5* 
XG (synthetic)  94 ± 6.1  102 ± 2.5  122 ± 4.5  130 ± 2.8  97 ± 6.3  106 ± 6.3  126 ± 6.3  132 ± 6.3* 
TP  96 ± 4.0  97 ± 3.8  119 ± 5.2  111 ± 4.3  105 ± 3.0  108 ± 5.0  127 ± 1.3*  122 ± 3.6 
TG  97 ± 4.0  113 ± 1.1  118 ± 5.2  191 ±3.3*  103 ± 5.2  126 ± 5.2  127 ±2.5  168 ± 1.5* 
DX  111 ±3.1  144 ± 2.3*  156 ± 4.1*  187 ± 2.5*  121 ±1.1  141 ±2.3*  154 ± 2.3*  174 ± 2.3* 
DH  101 ± 2.3  108 ± 4.0  172 ±4.0*  247 ± 2.3*  93 ± 4.1  112 ± 2.0  179 ± 2.3*  243 ± 2.3* 
1TX  92 ±2.1  96±3.2  115±3.2  132±1.8  94 ± 1.8  94 ± 1.8  131±2.3  144 ±2.1* 
PX  101 ±1.2  122 ± 0.9  167 ± 6.1*  164 ± 6.1*  94 ± 2.5  122 ± 1.5  179 ± 1.1*  218 ± 1.1* 
tDPX  90± 1.8  95± 1.8  93 ± 2.1  108 ± 4.2  110± 1.5  122 ± 2.1  129 ± 4.1  156 ± 3.2* 
CN (synthetic)  99 ± 2.3  94 ± 7.2  103 ± 2.5  108 ± 4.0  100 ± 3.2  98 ± 2.9  105 ± 3.2  123 ± 5.2 
Flavanones 
(hops) 
IX  94 ± 2.0  91 ± 6.0  92 ± 2.1  82 ± 5.2*  94 ± 1.9  94 ± 4..4  97 ± 1.5  98 ± 4.1 
6PN  101 ± 2.1  116 ± 2.1  129 ± 7.2  133 ± 2.1*  96 ± 7.2  105 ± 3.2  118 ± 2.9  116 ± 2.9 
8PN  84 ± 3.2*  78 ± 3.2*  106 ± 4.5  115 ± 1.9  126 ± 0.9  132 ± 1.2  140 ± 3.2*  157 ± 2.0* 
DPN  81 ± 0.9*  84 ± 0.9*  106 ± 2.6  127 ± 1.5*  140 ± 4.0*  143 ± 3.0*  139 ± 4.2*  154 ± 2.6* 
Continued. Table 3 continued. 
COMPOUND  2 DAYS  4 DAYS 
0.111M  1.0 µM  5.01A,M  101AM  0.1 µM  1.0 µM  5.011M  101AM 
Flavanone 
(grapefruit) 
NG  74 ± 1.5*  85 ± 1.5  75 ±1.5*  81 ± 1.5*  128 ± 6  134 ± 2.8*  133 ± 6  115 ± 6.0 
Isoflavone 
(soybean) 
GS  97 ± 5.3  106 ± 2.3  120 ± 5.3  142 ± 5.3*  101 ± 2.5  100 ± 2.5  108 ± 5.2  109 ± 2.5 
Flavone 
(synthetic) 
BNF  212 ± 4.3*  514 ± 2.3*  687 ± 3.2*  680 ± 2.3  135 ± 3.1  273 ± 1.8*  412 ± 3.2*  420 ± 2.1* 
Stilbene 
(grapes) 
RV  100 ±2.8  99 ±6.0  110 ±2.8  112 ±3.2  99±3.3  107±3.3  115 ±2.1  115 ±3.3 
Other 
BHA  98 ± 2.4  110 ± 3.3  117± 1.9  130 ± 2.5*  108 ± 4.5  115 ± 2.1  115 ± 2.3  120 ± 4.2 
BC  99 ±4.1  100 ±4.1  106±1.5  108 ±3.2  103 ±3.1  110 ±1.9  100 ±5.1  110 ±2.6 
DMBA  191 ± 2.9*  132 ± 4.5 
Values are means ± S.E. for 4 replicates. 
* Significantly different from control, p<0.025. 
aValues are expressed as percent of controls (treated with 0.1% ethanol). 
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percent cell death was 7.9 and 33.2% in 2 and 4 days respectively. Results 
are summarized in the Tables 4-6. 
Dose response evaluation 
Dose response studies were conducted to find out the optimal dose 
and the post treatment time required for maximum induction of QR. 
Experiments were continued for 5 days after the treatments and QR activity 
was measured daily. Mouse hepa 1c1c7 cells treated with 8 1.1M XN showed 
3.3-fold higher QR activity than cells exposed to ethanol (controls) on day 3. 
Doses of 10 IIM IX and 8µM DH gave the highest induction of QR on day 3 
and day 2, respectively. Results are illustrated in Figures 18 20 and the 
mean values of four replicates are summarized in Table 7. 
Inhibiting constant (1050) calculation 
The dosage which producing 50% inhibition of cell growth (IC50) was 
calculated for XN, IX and DH using mouse hepa 1c1c7 cells. A dose of 7.5 
.L.M XN produce 50% inhibition of cell growth in 2 days after treatment 
(Figure 21). IC50 of IX and DH (by linear extrapolation) were 13 and 25 I'M 
(Figures 22 and 23), respectively. 
Induction of QR and GST in CD1 mice fed with hop flavonoids 
Liver, kidney, stomach and intestinal cytosol of CD1 mice treated 
with hop compounds were tested for QR and GST activity. Results confirm 
that  5  or  25  mg/kg  dose  of  IX  by  gavage  were  able  to Table 4: Percent cell death of mouse hepa 1c1c7 cells treated with hop flavonoids and other compounds 
SRB assay). Values are expressed as percent of controls (treated with 0.1°/0 ethanol) a. 
PERCENT CELL DEATH 
COMPOUND  2 DAYS AFTER TREATMENT  4 DAYS AFTER TREATMENT 
0.1 1AM  141,M  5 IN  10 IN  0.1 IN  1 JIM  5 pt.M  10 JIM 
XN  0.8  1.2  10.0  28.8*  0.4  0.8  6.0  14.1 
XG  0.5  0.4  2.2  6.3  0.7  1.4  1.5  2.1 
TP  1.0  1.8  8.2  14.0  1.2  2.1  2.6  5 
TG  0.4  1.2  3.6  4.0  0.4  0.8  1.5  2.8 
DX  11.6  18.0  28.5*  38.5*  0.8  7.5  25.1*  41.2* 
DH  0.9  1.2  5.3  9.0  1.0  1.2  2.0  1.9 
TX  1.6  1.7  5.5  25.8*  0.9  1.3  1.5  2.8 
PX  4.3  9.7  37.0*  93.4*  1.2  3.5  31.8*  80.8* 
DPX  1.5  1.8  2.0  2.7  0.9  0.9  1.2  1.8 
CN  0.7  0.1  0.6  2.0  0  0  0.3 0.4 
IX  1.2  1.5  9.4  19.2  1.1  1.5  2.3  2.9 
6PN  1.7  8.5  4.1  17.6  -3.5  -1.2  2.7  8.6 
8PN  4.0  5.7  10.2  17.3  -2.5  1.6  4.7  2.0 
DPN  4.0  8.4  17.5  10.8  -2.4  -2.4  0.8  2.4 
NG  0.9  1.4  1.6  1.9  1.3  1.5  1.6  1.8 
GS  1.3  3.6  9.2  14.0  1.4  1.9  2.3  3
 
BNF  0.8  1.2  1.0  1.2  0.4  0.8  0.9  0.8
 
RV  3.4  10.4  6.7  12.4  -2.0  -1.2  -0.8  -0.8
 
BHA  0.8  0.8  1.0  0.4  0.0  0.8  0.9  0.8 
BC  1.2  1.5  1.9  0.4  1.5  1.9 
DM BA  15.6  4.2 
* Significantly different from control. p<0.025. 
aMeans of four replicates. Table 5: Percent cell death of rat hepatoma H4IIE cells treated with hop flavonoids and other compounds (SRB 
assay). Values are expressed as percent of controls treated with 0.1% ethanol) a. 
COMPOUND  PERCENT CELL DEATH 
2 DAYS AFTER TREATMENT  4 DAYS AFTER TREATMENT 
0.1 gM  1 jiM  5 p.M  10 p.M  0.1 pM  1  1..t.M  5 pM  10 gM
 
XN  -0.7  12.3
  95.1*  95.1*  -0.5  1.9  96.7*  97.9* 
XG  0.5  1.4  3.2  8.3  0.7  1.4  2.5  6.1
 
TP  3.1  2.4  9.5  16.6*  0.7  0.2  1.0  1.0
 
TG  -1.1  5.2  8.7  13.4  0.4  1.0  0.4  -0.2
 
DX  3.5  7.4  8.1  9.6  1.7
  1.6  2.1  1.5 
DH  4.0  -0.4  23.8*  69.7*  1.1  0.8  0.9  10.5
 
TX  1.6  1.7  5.5  15.8  0.9  1.3  3.5  5.8
 
PX  9.8  5.7  26.2*  81.8*  1.4  1.7  1.9  19.1*
 
DPX  1.6  1.8  2.3
  2.7  1.0  0.9  1.3  1.9
 
CN  0.7  1.1  1.6  1.9  0.2  0.5  0.3  0.4
 
IX  -3.7  -5.4  -3.6  14.7  0.9  1.0  0.9  0.8
 
6PN  7.0  7.8  9.7  11.1  1.6  1.8  2.0  1.9
 
8PN  4.2  9.7  12.5  2.0  2.1  2.2
 
DPN  -2.4  2.0  0.0  -9.0  0.4  0.9  1.2  0.7
 
NG  0.8  1.3  1.6  1.8  1.3  1.6  1.5  1.7
 
GS  3.5  14.3  19.1*  26.3*  1.4  1.8  2.5  2.2
 
BNF  -7.2  6.5  10.7  12.5  0.3  0.3  0.6  1.4
 
RV  4.7  7.1  6.5  20.9*  1.7  1.8  1.4  2.5
 
BHA  10.2  7.1  5.0  12.5  1.8  1.8  1.4
  1.8
 
BC  2.3  4.1  14.3  24.5*  1.8  1.4  1.8  2.2
 
DMBA1  21.8*
  3.6 
* Significantly different from control. p<0.025 
aMeans of four replicates Table 6: Percent cell death of human LNCaP cells treated with hop flavonoids and other compounds 
(SRB assay). Values are expressed as percent of controls (treated with  .1  a 
COMPOUND  PERCENT CELL DEATH 
2 DAYS AFTER TREATMENT  4 DAYS AFTER TREATMENT 
0.1 ptM  1 pt.M  51.tM  10 1AM  0.1 1.1M  1 gM  5 p.M  10 OA 
XN  0.7  0.4  1.8  7.9  0.0  0.7  2.1  33.2* 
XG  -0.2  0.7  0.6  .  0.6  1.8  1.9  1.8  1.8 
TP  1.4  1.8  2.2  2.2  1.8  1.1  1.8  1.4 
TG  0.8  0.7  1.1  1.4  1.8  1.5  1.8  2.0 
DX  1.0  1.2  1.4  0.6  0.9  1.9  1.6  0.0 
DH  1.8  1.9  2.0  2.0  1.4  1.4  1.8  2.1 
TX  1.5  1.8  1.2  1.5  1.3  3.3  1.6  1.6 
PX  1.1  2.0  2.4  4.8  0.8  1.2  1.6  3.6 
DPX  0.9  1.2  1.9  1.4  1.2  1.9  2.6  1.6 
CN  0.0  -0.1  0.3  0.0  1.6  1.8  2.0  1.8 
IX  1.4  1.1  1.8  2.2  1.8  1.9  1.8  1.8 
6PN  0.4  0.8  1.3  0.9  0.3  0.6  0.5  0.5 
8PN  0.3  0.3  1.1  1.4  0.5  0.7  1.5  1.0 
DPN  0.5  0.8  1.7  1.4  0.8  1.0  2.5  1.9 
NG  0.8  1.2  1.6  1.5  1.3  1.6  1.6  1.7 
GS  2.5  2.0  -4.5  2.9  2.2  1.4  2.3  2.7 
BNF  0  0.3  0.4  1.0  1.0  0.7  0.6  1.0 
RV  1.8  2.2  2.1  2.3  1.7  1.9  1.4  1.9 
BHA  0.8  0.9  1.3  1.6  0.9  0.9  1.0  1.3 
BC  1.0  1.3  1.4  2.0  0.7  0.9  1.1  1.0 
DMBA  6.4 - - 2.0 ­ -
ignificantly different from control. p<0.025 
'Means of four replicates. 400 
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Figure 18: Dose reaponse study conducted for quinone reductase in mouse hepa 1c1c7 cells using XN from 
hops as the test compound and 0.1% ethanol as the control. Cultures were exposed to range of concentrations 
as indicated in x axis and QR assays were conducted in every 24 hour period for 5 days (Table 7). 200 
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Figure 19: Dose reaponse study conducted for quinone reductase in mouse hepa 1c1c7 cells using IX from 
hops as the test compound and 0.1% ethanol as the control. Cultures were exposed to range of concentrations 
as indicated in x axis and QR assays were conducted in every 24 hour period for 5 days (Table 7). _-----­
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Figure 20: Dose reaponse study conducted for quinone reductase in mouse hepa 1c1c7 cells using DH from 
hops as the test compound and 0.1% ethanol as the control. Cultures were exposed to range of concentrations 
as indicated in x axis and QR assays were conducted in every 24 hour period for 5 days (Table 7). 54 
Table 7: Dose response study conducted for quinone reductase in mouse 
hepa  1c1c7  cells. QR activities  of  cells  treated  with  increasing
concentrations of XN, IX and DH in different time points are given in this 
table (Figures 18,19,20). Enzyme activity is expressed as percent of control
(treated  with 0.1% ethanol). Assays were performed day 1-5  post 
treatmentsa. 
COMPOUND  CONC.  QR ACTIVITY(percent of control) 
(P.M)  POST TREATMENT DURATION 
DAY 1  DAY 2  DAY 3  DAY 4  DAY 5 
XN	  1  112  200  192  157  146 
2  171  249  288  194  167 
4  232  328  307  219  188 
6  85  327  271  278  263 
8  77  261  330  257  254 
10  71  228  263  178  264 
12  70  158  123  106  100 
14  51  177 73  64  37 
16  78 52 36 20 27 
IX	  1  69  107 119 99  122 
2  74  106  124  108  89 
4  85  124  133  132  117 
6  88  129  137  108  125 
8  55  115  144  117  124 
10  116  132  162  133  120 
12  96  116  136  118  117 
14  56  102  127  113  115 
16  60  100  118  99  126 
DH  1  185  199  176  55  128 
2  242  287  237  77  177 
4  249  355  315  107  231 
5  282  341  323  105  218 
8  217  396  347  78  185 
10  190  373  271  55  129 
aAverage of four replicates 55 
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Figure 21: Calculation of inhibition constant (IC50) of xanthohumol for 
mouse hepatoma 1c1c7 cells. Mouse cells were exposed to increasing 
concentration of compound. Inhibition of cell growth is expressed as 
percent of control (treated with 0.1% ethanol). Each data point represents 
the mean of four replicates. SRB assay was performed on the day 2. 
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Figure 22: Calculation of inhibition constant of isoxanthohumol for 
mouse Hepa 1c1c7 cells. Cells were treated with a range of 
concentration of IX as indicated in x axis. Inhibition of cell growth is 
expressed as percent of control (treated with 0.1% ethanol). Each data 
point represents the mean of four replicates. SRB assay was performed 
on the day 2 after treatment. 57 
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Figure 23: Calculation of inhibition constant of 
dehydroxycycloxnathohumol hydrate for mouse hepa 1c1c7cells. 
Cells were treated with increasing concentrations of DH. SRB 
assay was performed on the day 2 post treatment. Inhibition of cell 
growth is expressed as a percent of control (treated with 0.1% ethanol). 
Each data point represents the mean of four replicates. IC50 value 
was obtained from extrapolation of the data points. 58 
induce QR and GST significantly in mice. The highest induction of QR 
occured in animals treated with 25 mg/kg IX (in liver cytosol). The  same 
dose of IX was able to increase the GST activity by 2.8-fold and 1.5-fold in 
intestine and liver, respectively. Figures 24, 25 (p.o. treated) and 26 (i.p. 
treated) illustrate the induction of QR and GST in CD1 mice treated with XN 
and IX. Results are summarized in Tables 8 and 9. However, XN  was 
unable to induce QR or GST activity in liver cytosol of rainbow trout (Figure 
27; Table 10). 
Western blot analysis 
Western blots were performed to test the hypothesis that hop 
flavonoids are monofunctional inducers of QR and will not induce the phase 
I enzyme CYP1A1. Hop compound such as XN, IX, DH, TP, TG, DX, and 
DPN, which gave a higher QR activity in cell culture experiments were used 
as test compounds. The nitrocellulose membranes with transferred proteins 
were probed with rabbit antibodies against rat CYP1A1. No band was 
observed in flavonoid-treated cell samples (Figure 28). X-ray films from 
western blots were quantified using a densitometer (Table 11). The results 
suggest that they do not increased CYP1A1 levels in mouse 1c1c7 (Figure 
29), rat H4IIE (Figure 30) and human LNCaP cells (Figure 31). DMBA was 
used as the positive control for CYP1A1  in western blotting.  Liver 
microsomes from female CD1 mice i.p. treated or gavaged with XN  or IX 
did not show significant increased CYP1A1 protein (Figures 32 and 33) 
over sesame oil (vehicle) treated controls. In contrast animals i.p. treated 
with BNF increased the CYP1A1 concentration 9-fold  over sesame oil 
treated controls (Figures 32 and 33). A western blot carried out using liver 
microsomes from rainbow trout treated with XN did not indicate increased 180 
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Figure 24: Quinone reductase activity in different tissues of CD1 mice treated (gavaged) with 5 or 
25 mg/kg body weight dose of xanthohumol or isoxanthohumol. Liver, kidney, stomach and intestine 
cytosols were analyzed for QR activity. Enzyme activity is expressed as percent of control (animals 
treated with sesame oil). Mean values of six animals and standard errors are given in Table 8. 400 
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Figure 25: GST activity in different tissues of CD1 mice treated (gavaged) with xanthohumol 
and isoxanthohumol. Liver, kidney, stomach and intestine were analyzed for GST activity. 
Mean values obtained from six animals and standard errors are given in Table 8. Table 8:  Quinone reductase and glutathione S-transferase activities in CD1 mice fed with 5 or 25 mg/kg body 
weight dose of XN or IX from hops. Enzyme activity was compared with control animals treated with sesame oil. 
Values are expressed as percent of controls. 
QR activity (percent of control)  GST activity (percent of control) 
COMPOUND  XN  IX  XN  IX 
5 mg/kg  25 mg/kg  5 mg/kg  25 mg/kg  5 mg/kg  25 mg/kg  5 mg/kg  25 mg/kg 
LIVER  126 ± 3.1  119 ± 1.9  129 ± 5.8*  157 ± 3.2*  117 ± 9.4  96 ± 8.2  97 ± 2.7  157±7.1* 
KIDNEY  93 ± 2.7  96 ± 2.5  110 ± 5.1  129 ± 4.5*  60 ± 4.6  73 ± 4.8  101 ± 2.1  122 ± 1.6 
STOMACH  109 ± 0.7  115 ± 1.6  108 ± 1.4  116 ± 1.7  111 ±9.0  115 ± 22  111 ±34  120 ± 38 
INTESTINE  76 ± 2.3  76 ± 3.2  89 ± 1.2  93 ± 4.0  111 ± 10  185 ± 25*  264 ± 76*  288 ± 41* 
Values are means ± S.E. for 4 replicates. 
* Significantly different from control, p<0.025. 250 
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*Significantly different from control, p<0.025. 
Figure 26: QR and GST activity in CD1 mice treated (i.p.) with XN, IX or BNF. A body weight dose of 
5 or 25 mg/kg of hop flavonoids or 5 mg/kg of BNF were used as treatments. Protein concentration is 
expressed as percent of control (animals treated with sesame oil). Mean values of six animals and 
standard errors are given in Table 9. 63 
Table 9:  Quinone reductase and glutathione S-transferase activity in the 
liver cytosol from CD1 mice treated (i.p) with a 5 or 25 mg/kg body weight 
dose of XN or IX from hops or 5 mg/kg body weight dose of BNF. Enzyme 
activity was compared with control animals treated with sesame oils. 
TREATMENT 
(mg/kg body weight) 
ENZYME ACTIVITY (percent of control) 
QR  GST 
XN 5 
XN 25 
IX 5 
IX 25 
BNF 5 
127 ± 5.2 
109 ± 2.13 
123 ± 11.3 
136 ± 6.1* 
190 ± 13.2* 
104 ± 5.69 
95 ± 8.47 
98 ± 7.65 
110 ± 6.2 
119 ± 9.45 
Values are means ± S.E. for 4 replicates. 
* Significantly different from control, p<0.025. 
aValues are expressed as percent of controls. XN 1  XN 10
 
TREATMENT (mg/kg body weight)
 
*Significantly different from control, p<0.025 
Figure 27: Quinone reductase and glutathione S-transferase activity in liver cytosol from rainbow 
trout i.p. treated with 1 or 10 mg/kg body weight of xanthohumol. Enzyme activity is expressed as 
percent of control (treated with 0.1% of ethanol). Assay results are summarized in Table 10. 65 
Table 10: Quinone reductase and glutathione S-transferase activity in the 
liver cytosol from rainbow trout fed with 1 or 10 mg/kg dose of xanthohumol. 
Enzyme activity is expressed as percent of control animals treated with 
ethanol a. 
ACTIVITY (percent of control) 
TREATMENT 
QR  GST 
XN 1 mg/kg body weight  37  130 
XN 10 mg/kg body weight  94  140 
* Significantly different from control. p<0.025 
aAverage of four replicates 66 
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Figure 28: CYP1A1 concentrations in mouse 1c1c7, rat H4IIE and human 
LNCaP cells treated with 5 pM concentration hop flavonoids. DMBA (1c1c7 
and H4IIE cells) and BNF (LNCaP cells) was used as the positive controls. 
In the western blot experiment, nitrocellulose membranes were probed with 
1251 protein A for 1 hour and exposed to Kodak films for 24 hours. (A) 1c1c7 
cells, (B) H4IIE cells and (C) LNCaP cells. 1= positive control (DMBA or 
BNF); 2= ethanol; 3= XN; 4= IX; 5= DH; 6= TP; 7= TG; 8= DPN; 9= DX; 
10= CYP1A1 standard. Values obtained from densitometric scanning of the 
x-ray films from western blotting are summarized in Table 11. Table 11: CYP1A1 concentration in mouse hepa 1c1c7, rat H4IIE and human LNCaP cells treated with hop 
flavonoids. DMBA (1c1c7 and H4IIE cells) and BNF (LNCaP cells) was used as the positive controls. Enzyme 
activity is expressed as percent of control (treated with 0.1% ethanol. Numerical values were obtained from 
densitometric scanning of X-ray film from western blot. 
TREATMENT  CYP1A1 CONCENTRATION (percent of control) 
(COMPOUND) 
1c1c7  H4IIE  LNCaP 
ETHANOL  100  100  100 
DMBA (BNF*)  454  1666  833* 
XN  54  0  91 
IX  27  0  75 
DH  22  0  8 
TP  45  0  150 
TG  54  0  -
DPN  36  0  -
DX  72  0  -500 
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Figure 29: CYP1A1 activity in mouse hepa 1c1c7 cells treated with 5 [IM concentration 
of hop flavonoids or DMBA. Protein concentration is expressed as percent of control (treated with 
0.1% ethanol). Numerical values (see Table 11) were obtained from densitometric scanning of 
X-ray film from western blot (Figure 28). Weatern blot was performed on day 2 after treatment. 
(MLX = mother liquor flavonoids). 1800 
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Figure 30: CYP1A1 activity in rat hepatoma H4IIE cells treated with 5 mM concentration of hop 
flavonoids or DMBA. Protein concentration is expressed as percent of control (treated with 0.1% 
ethanol). Numerical values (Table 11) were obtained from densitometric scanning of X-ray film 
from western blot (Figure 28). Western blot was carried out on 2 days post treatment. 1000 
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Figure 31: CYP1A1 activity in human LNCaP cells treated with 5 I'M concentration of hop flavonoids 
or BNF. Protein concentration is expressed as percent of control (treated with0.1% ethanol). Western 
blot was carried out on 2 days post treatment. BNF was used as the positive control. Values (Table 11) 
for this graph were obtained from densitometric scanning of the X-ray film from western blotting (Figure 28). 1000 
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Figure 32: Levels of CYP1A1 in CD1 mice treated (i.p.or gavage) with XN, IX  or BNF. A body 
weight dose of 5 or 25 mg/kg of hop flavonoids or 5 mg/kg of BNF were used as treatments. 
BNF was used for i.p. treatments as a positive control. Protein concentration is  expressed 
as percent of control (animals treated with sesame oil). Numerical values (see Table 12 ) 
were obtained from densitometric scanning of X-ray film from western blotting (Figure 33). 72 
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Figure 33: Western blot of liver microsomes from CD1 mice treated with 
XN, IX or BNF probed with rabbit antibodies raised against rat CYP1A1. 
Forty pg of microsomal protein were used for electrophoresis. UN  = 
untreated animals, CON = animals treated with vehicle (sesame oil). Five 
and 25 mg per kg body weight dose of the test compounds were (1) i.p. 
injected or (2) gavaged to the test animals. Four separate western blots 
were completed with different individual animal samples from each 
treatment group. One representative x-ray film is presented above. 73 
CYP1A1 protein (Figures 34-35). These results confirm that XN or IX did 
not increase CYP1A1 concentration in CD1 mice and XN did not increased 
CYP1A1 protein in rainbow trout liver microsomes. Values obtained from 
densitometer scanning are given in Table 12 and 13 (mice and rainbow 
trout respectively). 
55 lcD 
C  XN 1  XN 10	  CYP1A1 
Standard 
Figure 34:  Western blot of liver microsomes from rainbow trout treated 
with xanthohumol probed with CYP1A1. Values obtained from densitometer 
scanning of the x-ray film are presented in Table 13. (C= ethanol treated 
control; XN1= dose of 1 mg/kg xanthohumol; XN10= dose of 10 mg/kg 
xanthohumol, ST= CYP1A1 standard). 120 
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Figure 35: CYP 1A1 levels in liver microsomes from rainbow trout treated with xanthohumol  in ethanol 
or ethanol as a control. Protein concentration is expressed as a percent of control. Numerical values 
(Table 13) were obtained from densitometric scanning of the X-ray film from western blot (Figure 34). 75 
Table 12: Relative CYP1A1 concentrations in liver microsomes from CD1 
mice treated (gavage or i.p) with a 5 or 25 mg/kg body weight dose of XN 
or IX . 5 mg/kg body weight dose of BNF was used as a positive control in 
i.p. treatments.  Protein concentration is expressed as percent of control 
(treated  with  sesame  oil).  Numerical  values  were  obtained  from 
densitometric scanning of X-ray film from western blot. 
TREATMENT  CYP1A1 CONCENTRATIONS (percent of 
(COMPOUND)  control) 
i.p.  p.o. (gavage) 
CONTROL  100  100 
XN 5  91  122 
XN 25  109  100 
IX 5  109  122 
IX 25  154  166 
BNF  909 
Table 13: CYP1A1 concentration in liver microsomes from rainbow trout 
treated with 1 or 10 mg/kg body weight dose of XN. Protein concentration is 
expressed as percent of control (animals treated with ethanol). Numerical 
values were obtained from densitometer scanning of x-ray film from western 
blot. 
CYP1A1 
TREATMENT  CONCENTRATION 
(percent of control) 
XN 1 mg/kg body weight  67 
XN 10 mg/kg body weight  76 76 
DISCUSSION
 
Induction of QR activity in vitro. QR catalyzes the two-electron reduction 
of a variety of compounds including quinones, azo compounds, transition 
metals and quinoneimines. Several antineoplastic compounds, including 
mitomycin C are also activated by QR. Powis et a/. (1987) reported that a 
putative  hepatotoxic  metabolite  of  acetaminophen  (a  quinoneimine 
compound), N-acetyl-p-benzoquinoneimine is reduced and detoxified by 
QR. No natural substrates for QR have been identified. However, QR is 
thought to participate  in the metabolism of vitamin K. One possible 
physiological function of QR is to regenerate the antioxidant forms of alpha-
tocopherol, that is, to catalyze the reduction of alpha-tocopherone (an 
oxidized product of alpha-tocopherol) to the antioxidant form, alpha­
tocopherolhydroquinone (Siegel et al., 1997). 
Inducers of QR are classified as monofunctional and bifunctional 
(Prochaska and Talalay, 1988). Monofunctional inducers increase the 
activities or levels of QR but not phase  (CYPIA) enzymes.  The I 
antioxidant response element (ARE) in the upstream region of the human 
QR gene is required for induction by monofunctional inducers (Wang and 
Williamson, 1996; Xie et al., 1995). A functional Ah receptor system is not 
required for induction by monofunctional inducers of QR (Prochaska and 
Talalay, 1988; Yannai et al., 1998).  Induction of enzymes by bifunctional 
agents (inducers of both phase I and phase II enzymes) are mediated by 
the ARE and the xenobiotic-responsive element (XRE) in the 5'-region of 
the QR gene (Favreau and Pickett, 1991; Jaiswal, 1994). In rat hepatoma 
cells, BNF (a bifunctional inducer) binds directly to the XRE via Ah receptor 
to induce both QR and CYP1A1. A metabolite of BNF is responsible for 
inducing QR via ARE. In the present study, seven flavonoids (XN, IX, DH, 
TP, TG, DPN and DX) from hops tested for induction of phase I and phase 
II  enzymes were found  to  induce QR without increasing CYP1A1 77 
concentration in mouse Hepa 1c1c7 cells. These results suggest that these 
hop flavonoids may be monofunctional inducers of QR, probably by 
activating the ARE, but not the XRE.  However, further studies using 
chloramphenicol acetyl transferase (CAT) reporter constructs transfected in 
Hep G2 cells are needed to definitely establish that the hop flavonoids 
induce QR through the ARE. 
Structural features of flavonoids are important for induction of QR 
(Uda et al., 1997; Yashushi et al., 1997).  The flavonols are the most 
effective inducers of QR in mouse Hepa 1c1c7 cells and that flavanols and 
flavans are either ineffective or are weak inducers of QR.  Specifically, a 
double bond at 2-3 carbon atoms in ring C of the flavonoid structure is 
essential for QR induction. On the other hand, hydroxyl groups in the ring B 
is not essential for QR induction. A 3-hydroxyl group in ring C increases 
QR activity but is not essential for induction. The hop flavonoids are either 
chalcones (have A and B rings and an open C-ring) or flavanones (have A, 
B and C rings, with no double bond at 2-3 carbon atoms) carrying methoxy, 
hydroxyl, prenyl or geranyl in different positions. These substituents present 
in the structure of hop flavonoids may influence the induction of QR activity. 
In general, the hop chalcones increase QR activity better than flavanones in 
mouse Hepa 1c1c7 cells (Table 1) suggesting that the ring C is not 
essential for induction of QR. A prenyl or a geranyl group added to a 
flavanone increases QR activity since IX, 6PN, 8PN and DPN are inducers 
whereas NG [a flavanone found in grapefruit (not present in hops) with no 
prenyl or geranyl substituents] is not an inducer of QR in Hepa 1c1c7 cells. 
An extra prenyl group enhances QR induction as supported by higher QR 
activity in Hepa 1c1c7 cells treated with DPN (has two prenyl groups at the 
6 and 8 positions) than in those treated with other flavanones with one 
prenyl group (IX, 6PN and 8PN). 
The chalcones were found to induce QR activity in varying degrees. 
A prenyl (as in TP) or a geranyl (as in TG) substituent in a chalcone is 78 
important for induction of QR activity since the chalcone, CN (semi-
synthetic, not present in hops) with no prenyl or geranyl groups is a very 
weak inducer of QR in Hepa 1c1c7 cells (Table 1). Of the hop chalcones 
examined, DH and XN (both at 10 gM) were the most potent inducers of QR 
in  Hepa 1c1c7  cells,  increasing QR activity  5.4-fold  and  3.7-fold, 
respectively. Other hop chalcones with two (PX) or three (DPX) prenyl 
groups increased QR activity only 2-fold or lower, suggesting that an extra 
prenyl group in a chalcone does not enhance induction of QR. The position 
of the 0-methyl group in hop chalcone also has an influence on QR 
induction since XN (with  0-methyl group at 6' position) was a better 
inducer of QR activity XG (with 0-methyl group at 4' position). 
Another way to evaluate the potency of the individual flavonoids as 
inducers of QR is to analyze the magnitude of induction of QR at 0.1 p,M, 
the lowest concentration of flavonoid used in the cell culture studies.  In 
mouse Hepa 1c1c7 cells, only DX, 6PN and DPN induced QR at 0.1 1AM, 
and the induction was less than 2-fold.  At the same concentration, BNF 
(positive control), induced QR 2.2-fold. At 0.1 p.NA, GS, RV and BHA, which 
are known inducers of QR, did not induce QR activity in this cell line. These 
results indicate that certain hop flavonoids, unlike GS, RV or BHA, are 
capable of inducing QR in Hepa 1c1c7 cells at concentrations of 0.1 i.IN/1. 
Comparison of mouse Hepa 1c1c7 cells with rat H4llE and human 
prostate cancer LNCaP cells. The mouse Hepa 1c1c7 cells is the most 
commonly used model for assessing the induction of QR by various 
chemicals (Zhang et al.,  1992; Yannai et al.,  1998; Prochaska and 
Santamaria,1988; Uda et  al.,  1997). However, there have been no 
comparative studies that had been done to demonstrate that the results 
obtained from this mouse cell line can be duplicated in cell lines from other 
species. QR may exist in different forms in different species and their 79 
regulation of expression could vary among species.  The present study 
shows that XN, at 10 gM, induces QR approximately 3-fold in Hepa 1c1c7 
cells whereas in rat H4IIE cells, the same treatment resulted in a decrease 
in QR activity (Table 2).  In human LNCaP cells, QR activity was increased 
1.5 fold (Table 3), compared to 3.28-fold in Hepa 1c1c7 cells.  At 0.1 OA, 
DX, and DPN significantly induced QR in mouse Hepa 1c1c7 cells but not 
in human LNCaP cells. In addition, GS (at 10 !ANA), the isoflavone found in 
soy products, induced QR 1.4-fold in Hepa 1c1c7 cells (Table 1) and in 
human LNCaP cells (Table 3) but was ineffective in rat H4IIE cells (Table 
2).  In the human colon cancer cell line, Co1o205, GS induced QR 8-fold 
(Wang et al., 1998). These observations indicate that induction of QR in 
Hepa 1c1c7 cells cannot be extrapolated to other species and that induction 
of QR vary also with the cell line of the same species. There is a need to 
examine the induction of QR in Co1o205 cells by hop flavonoids since this 
cell line has been more sensitive to QR induction by GS and the cell line is 
of human origin making it more relevant model for studying induction of QR 
in humans. 
QR activity in cell cultures was evaluated after 2 or 4 days of 
exposure to the flavonoids and other compounds. By examining the time-
dependent changes in QR activity,  it  is possible to obtain information 
regarding the possible role of metabolism in QR induction.  The only 
obvious difference in QR induction between 2 and 4 days was observed in 
mouse Hepa 1c1c7, rat H4IIE and LNCaP cells treated with BNF (at all 
doses) in which QR induction was greater at 2 days than at 4 days (Table 
1). BNF was found to induce CYP1A which could catalyze the conversion 
of this flavonoid to products less active in inducing QR. 
BHA is a potent inducer of liver QR when fed to mice (Benson et al., 
1980) but in the present study, this compound was found to be a weak 
inducer of QR in rodent and human tumor cell lines. Unlike in mouse liver, 
the three cell lines may lack the enzymes required to convert BHA to tert­80 
butyl hydroquinone (TBHQ). TBHQ is a potent inducer of QR (Montano 
and Katzenellenbogen, 1997). Therefore, in vitro studies using cell cultures 
may fail to detect inducers which have to be transformed first by liver 
enzymes to products that are the ultimate inducers of QR. 
The increase in QR activity in human LNCaP cells or in other cell 
lines after exposure to flavonoids may be explained by increase in gene 
transcription, mRNA stabilization or decreased protein degradation. LNCaP 
cells has been reported to express the human QR form, NQ01 wild type 
(Steiner et al., 1999). The human NQ01 gene contains the XRE and ARE 
which are activated by polycyclic aromatic hydrocarbons and phenolic 
antioxidants, respectively (Jaiswal, 1994).  As phenolic compounds, it  is 
most likely that the hop flavonoids increase QR activity in LNCaP cells 
through the ARE. The lack of induction of CYPIA protein indicates that the 
XRE is not involved in the induction of QR by the hop flavonoids. 
The inability of XN to induce QR in rat H4IIE cells may be explained 
by the unusual sensitivity of this cell line to the cytotoxic effects of the 
flavonoid.  In this cell line (Table 5), XN, at 5 and 10 1.1M, caused a 95 % 
lethality whereas in mouse Hepa 1c1c7 cells (Table 4) and human LNCaP 
cells (Table 6), cell deaths were 28% and 7.9%, respectively. The three cell 
lines used in this study also exhibited differential sensitivity to the toxic 
effects of other hop flavonoids (Tables 4, 5 and 6). The finding that XN is 
highly toxic to rat H4IIE cells may have some useful application in the 
treatment of certain forms of liver tumors. 
Induction of QR in vivo.  In the intact animal, the flavonoids could be 
metabolized by xenobiotic-metabolizing enzymes to products that could be 
more or less potent than the parent compound in inducing QR. These 
enzymes may not be present or expressed in the cell lines used as models 
for examining induction of QR in vitro.  Therefore, induction of QR in vitro 
may not accurately predict the induction of QR in vivo  if the parent 81 
compound is metabolized or degraded by enzymes in the liver and other 
tissues. 
Initial studies showed that XN is metabolized by rat liver cytochrome 
P450 enzymes to 5"-(2-hydroxyisopropy1)42",3":3',41dihydrodrofurano-2',4­
dihydroxy-6'-methoxychalcone and a dehydrocycloxanthohumol derivative 
(Yilmazer et al. 1999). These metabolites could be less or more effective 
than XN in inducing QR.  In the case of BHA, a hepatic 0-demethylase 
converts this antioxidant to tert-butyl hydroquinone (TBHQ) which is a 
potent  activator  of  the ARE  in  the QR gene  (Montano  and 
Katzenellenbogen, 1997). Feeding of BHA (0.75% in the diet) to mice for 10 
days results in a 4- to 10fold induction of liver QR, depending upon the 
mouse strain (Benson et al., 1980; Horie et al., 1989; De Long et al., 1985). 
Thus, In vivo studies are needed to confirm the results of our in vitro studies 
in terms of induction of QR by XN. 
The effects of XN and IX, administered by gavage or by i.p. injection, 
were examined in CD-1 mice, a species known to be responsive to inducers 
of QR (Benson et al., 1980; De Long et al., 1985).  XN, when given by 
gavage, increased QR activity of mouse liver cytosol by 26 percent at a 
dose of 5 mg/kg (Table 8). At 25 mg/kg, XN did not significantly induce QR 
activity of mouse liver cytosol. On the other hand, IX, at doses of 5 and 25 
mg/kg, increased QR activity of mouse liver cytosol by 29% and 57%, 
respectively. These results are not consistent with those obtained from in 
vitro studies using mouse Hepa 1c1c7 cells in which XN was better than IX 
in inducing QR. In this cell line, XN, at 5 or 10 ilM, increased QR activity 
approximately 3-fold whereas IX at these concentrations increased QR 
activity only 1.3-fold.  It  is possible that in vivo, gut and liver enzymes 
metabolize XN to products that are less active in inducing QR than the 
parent compound. In contrast, IX could be metabolized in the intact animal 
to products that are more effective than the parent compound in inducing 
QR. When XN or IX was given i.p., the induction of QR was no greater than 82 
what was obtained from the experiment using  orally  administered 
flavonoids, ruling out the influence of gut metabolism and absorption  on QR 
induction. BNF (5 mg/kg, i.p.) increased QR activity in mouse liver cytosol 
only 1.9-fold (Table 9) but in Hepa 1c1c7 cells, this flavonoid increased QR 
activity 10-fold at 5 ptM (Table 1).  Based on these findings, the low 
induction of QR resulting from XN or BNF administration to mice may also 
probably be related to dosage, duration of treatment, and  manner of 
administration. BHA is a more potent inducer of QR when given in the diet, 
rather when injected i.p. (Cha et aL, 1982). 
The inability of XN to induce QR in mouse liver at doses of 5 or 25 
mg/kg given orally or i.p. is puzzling. There could be induction of QR at the 
protein level at 25 mg/kg but this induction could not be detected using 
enzyme activity measurement if the induced enzyme is inactivated by a 
metabolite of the parent compound. Western blot analysis is needed to 
demonstrate that XN, at 5 or 25 mg/kg, increases QR protein in mouse 
liver. Studies on the inhibitory effect of XN or its metabolites on QR activity 
of mouse liver is also warranted since other flavonoids such  as quercetin 
(Wu et al., 1997) and wogonin (Liu et al., 1990) are strong inhibitors of QR 
activity. Although quercetin itself is an inhibitor of QR, this flavonoid  has 
also been reported to be an inducer of QR activity in  mouse Hepa 1c1c7 
cells (De Long et al., 1986). 
Induction of QR in extrahepatic tissues of CD-1 mice. The two forms of 
QR are differentially expressed in human tissues. Jaiswal (1994) has 
reported that the NQ01 gene is expressed in all human tissues whereas 
the NQO2 gene is expressed in human heart, brain, lung, liver and skeletal 
muscle but not in placenta.  The expression and induction of QR in a 
particular tissue may determine the susceptibility of that tissue to the toxic 
and carcinogenic effects of quinones. Induction of QR has been shown to 
vary with tissues. For certain chemicals such as BHA, induction of QR has 83 
been observed in the liver but not in the small intestine of Sprague-Dawley 
rats (Vargas et al., 1998). In contrast, feeding of rats with soy flour and soy 
protein isolates which contain the isoflavones, genistein and daidzein, 
produces a 12- to 14 -fold increase in QR activity in the colon but only a 1.4­
fold increase in liver QR (Appelt and Reicks, 1997). QR induction in rat 
tissues after feeding 0.4% ethoxyquin ranges from 1.39-fold in glandular 
stomach to 3.7-fold in liver and colon (Spencer et al., 1990). In the present 
study in which CD-1 mice were gavaged with XN or IX, QR induction was 
greatest in the liver (Table 8). There was no significant induction of QR in 
the stomach or small intestine of mice following XN or IX treatment. 
Induction of CYP1A and GST.  Western blot analysis was used to 
determine if hop flavonoids are monofunctional or bifunctional inducers of 
QR.  Bifunctional inducers will be expected to induce CYP1A in the cell 
lines and in the mice treated with flavonoids.  For cancer prevention 
programs, it is preferable to use compounds that are inducers of QR but not 
of CYP1A. Induction of CYP1A may increase cancer risk because they will 
enhance the bioactivation of carcinogenic polycyclic aromatic hydrocarbons 
and other procarcinogens.  Since some flavonoids act as bifunctional 
inducers of QR, the hop compounds were tested for induction of CYP1A1 
activity. BNF and DMBA were used as positive controls for CYP1A1 in cell 
culture studies and BNF was used in the in vivo mouse experiments. The 
results shown in Table 11 confirm that DMBA and BNF are inducers of 
CYP1A1 rodent and human cell lines. Unlike DMBA, none of the hop 
flavonoids examined induced CYP1A in mouse Hepa 1c1c7 cells. On the 
contrary, some of the hop flavonoids caused a reduction in the levels of 
CYP1A1 in Hepa 1c1c7 cells (Table 11).  By downregulating CYP1A1 
expression, the hop flavonoids may act as a cancer chemopreventive agent 
by block the activation of procarcinogens by CYP1A. 84 
In trout injected i.p. with XN (Table 13) or in mice treated with XN or 
IX by gavage or  i.p.  injection  (Table  12), CYP1A levels were not 
significantly increased above control levels. The results of these in vitro and 
in vivo studies suggest that the hop flavonoids are monofunctional inducers 
of QR. 
Limited studies were performed on the induction of GST by hop 
flavonoids.  Like QR, GSTs such as GST Ya can be induced in animal cells 
exposed to electrophilic compounds and phenolic antioxidants and the 
induction is mediated by the electrophile-responsive/antioxidant-responsive 
elements, EpRE/ARE (Prestera and Talalay, 1995). Therefore, compounds 
that activate the ARE are expected to induce both QR and GST Ya. Our 
experiments showed that when XN given by gavage did not induce QR in 
the liver of mice.  In the small intestine, GST activity was increased 1.85­
fold by XN at 25 mg/kg. In contrast, IX, at 25 mg/kg, induced GST activity 
1.57-fold in liver and 2.88-fold in the small intestine of mice (Table 8). At 5 
mg/kg, IX induced GST activity in small intestine but not in liver.  These 
results suggest that another detoxifying enzyme, GST, can be induced by 
XN and IX in certain animal tissues. 85 
CONCLUSION
 
These studies were conducted to evaluate the possibilities of using 
novel flavonoids (chalcones and flavonones with prenyl or geranyl groups) 
from hops and beer as cancer chemoprevention agents. To help assess the 
influence of prenyl or geranyl groups on biological activity, other flavonoids 
with no prenyl or geranyl groups such as CN (a semi-synthetic chalcone) 
and NG (a natural flavanone in grapefruit) were also evaluated. GS, a 
monofunctional inducer of QR, and BNF, a bifunctional inducer, was used 
as a positive controls. The hypothesis was that the hop compounds will 
induce phase II carcinogen detoxifying enzymes such as QR and GST 
without inducing the phase I enzyme, CYP1A1. All the compounds were 
tested using three in vitro models such as the mouse Hepa 1c1c7 cells, rat 
hepatoma H4IIE cells and the human prostate cancer cell line, LNCaP. XN, 
the most abundant flavonoid in hops, and IX, the most abundant flavonoid 
in certain brands of beer, were tested in vivo using CD1 mice. XN also was 
tested in rainbow trout for its ability to induce QR and CYP1A1. 
In mouse Hepa 1c1c7 cells, all the chalcones (XN, XG, TP, TG, DX, 
DH, TX, PX and DPX) from hops and/or beer examined were able to induce 
QR. The hop chalcones were more effective than the hop flavonones as 
inducers of QR in this cell line.  DH and XN were the two most effective 
chalcones in inducing QR in mouse Hepa 1c1c7 cells and in human 
prostate cancer LNCaP cells.  Induction of QR activity in rat hepatoma 
H4IIE cells cannot be reliably assessed because this cell line was very 
sensitive to the cytotoxic effects of XN and other hop flavonoids at doses (5 
and 10 p,M) used in the QR assays. The cytotoxic activity of XN in rat H4IIE 
cells may have important implications in the treatment of certain forms of 
liver tumors. 
The in vivo studies showed that XN (5 mg/kg, by gavage) were able 
to induce QR activity by 29% in mouse liver cytosol. Intestinal GST but not 86 
liver GST was significantly increased by XN at 25 mg/kg. Western blot 
experiments did not show increased concentration of CYP1A1 in  mouse 
1c1c7 cells after treatment with XN and other hop chalcones. Instead, the 
hop flavonoids reduced the levels of CYP1A1, a property that could be 
useful in the preventing the metabolic activation of carcinogens mediated by 
CYP1A1. These results also suggest that XN and other hop chalcones are 
monofuctional inducers of phase II carcinogen detoxifying enzymes (QR ). 
The flavanones (IX, 6PN, 8PN and DPN) from hops and beer, like 
the chalcones, were found to induce QR mouse hepatoma 1c1c7 cells. 
However, IX, a flavanone isomer of XN, failed to induce QR in human 
LNCaP cells. When IX was given by gavage to mice, it induced both QR 
and GST significantly in mouse liver and stomach. CYP1A1 protein was 
not increased in the cell lines and in mouse liver. These results indicate that 
IX acts as a monofuctional inducer of phase II enzymes in vitro and in vivo. 
The presence of prenyl or geranyl groups  in  chalcones and 
flavanones appeared to be important in the induction of QR in mouse Hepa 
1c1c7 cells. Chalcones such as CN and flavanones such as NG, with  no 
prenyl or geranyl groups, did not induce QR activity in mouse Hepa 1 c1c7 
cells, suggesting that prenyl and geranyl substituents are important in the 
induction of QR by these flavonoids. The presence of two prenyl groups in 
a flavanone (DPN versus 6PN or 8PN) enhanced the induction of QR. In 
contrast, the presence of two (PX) or three (DPX) prenyl groups in a 
chalcone has no enhancing effect on the induction of QR by prenylated 
chalcone such as XN or TP. The isoflavone, GS, unlike the flavanone, NG, 
slightly induced QR in mouse Hepa 1c1c7 cells. However, in human colon 
cancer cell line, Co1o205, GS increased QR activity 8-fold. 
As a whole our studies show that certain prenylated chalcones hops 
such as XN and DH are monofunctional inducers of QR. As monofunctional 
inducers of QR, they could be potentially useful in the prevention of cancers 
produced by carcinogenic quinones.  However, there is a need to further 87 
evaluate the ability of these compounds and other hop flavonoids to induce 
QR in another human cancer cell  line, Co1o205, cells that are more 
responsive than LNCaP cells to QR inducers like GS.  Future studies 
should be directed also in elucidating the mechanisms (e.g., activation of 
the ARE response element of the NQ01 and NQO2  genes, mRNA 
stabilization, decreased protein degradation) by which QR is induced by the 
hop flavonoids in human cells. 88 
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